{"id":2299,"date":"2008-04-07T05:02:39","date_gmt":"2008-04-07T09:02:39","guid":{"rendered":"https:\/\/www.med.unc.edu\/dms\/dms\/fax-journal\/past-issues\/2007-2008-edition\/40th-annual-john-b-graham-research-society-abstracts\/"},"modified":"2018-12-04T15:03:10","modified_gmt":"2018-12-04T20:03:10","slug":"40th-annual-john-b-graham-research-society-abstracts","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/dms\/past-issues\/2007-2008-edition\/40th-annual-john-b-graham-research-society-abstracts\/","title":{"rendered":"40th Annual John B. Graham Research Society Abstracts"},"content":{"rendered":"<div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">A Novel Methodology for Endothelial Progenitor Cell Enumeration in Clinical Trials Based on Mononuclear Cell Cryopreservation<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Stacie Adams BS, Sunil V. Rao MD, Robert A. Harrington MD, Thomas J. Povsic MD PhD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background:\u00a0 Increasing evidence of the role played by circulating endothelial progenitor cells (EPCs) in vascular repair has led to interest in the clinical use of EPC enumeration.\u00a0 EPC mobilization is a key secondary endpoint of the REVEAL study, a multi-site clinical trial assessing the effect of acute erythropoietin administration on infarct size.\u00a0 Current EPC enumeration techniques require specialized laboratory techniques and immediate analysis, which poses significant barriers to assessing EPCs in the clinical setting where personnel may have limited laboratory experience and access to only basic equipment.\u00a0 To overcome these barriers, the development of a simplified protocol for isolating and storing mononuclear cell specimens is essential.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Methods:\u00a0 We compared the numbers of EPCs enumerated in samples processed immediately after acquisition with EPCs enumerated in samples stored for 24 hours or cryopreserved mononuclear cell samples using two EPC identification strategies: cell surface marker expression (CD133\/CD34) and aldehyde dehydrogenase activity (ALDH^br cells).\u00a0 EPCs identified in duplicate time points were plotted, and correlation co-efficients determined.\u00a0 We then implemented and assessed the feasibility of the mononuclear cell cryopreservation strategy in the REVEAL trial.\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0Results:\u00a0 The correlation coefficients for duplicate samples using the CD133\/CD34 analysis (r=0.59 for cryopreserved samples, r=0.841 for overnight storage) and the ALDH^br analysis (r=0.894 for cryopreservation, r=0.880 for overnight storage) were high, however, correlation was higher with the ALDH^br assay (p<0.002 for comparison of correlation coefficients).\u00a0 Of the first 58 REVEAL study participants drawn from 9 clinical sites, samples from 32 participants from 7 sites provided sufficient cells for EPC analysis at multiple time points.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Conclusion:\u00a0 EPCs can be reliably determined in cryopreserved mononuclear cell samples based on ALDH activity.\u00a0 Despite barriers, this strategy combined with central core lab EPC analysis is feasible in clinical trials.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Evaluating Knee and Total Body Burden of Osteoarthritis with Synovial Fluid and Serum Cartilage Oligomeric Matrix Protein (COMP)<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Shelby Addison, R Edward Coleman, Sheng Feng, Gary McDaniel, So Yeon Kong, Virginia Byers Kraus<\/span><\/p>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Objective. To evaluate the association of cartilage oligomeric matrix protein (COMP) levels, both in the serum and in the synovial fluid, with local and systemic measures of osteoarthritis (OA) severity.\u00a0\u00a0 Methods. Knee joint synovial fluid (SF) and serum were obtained from 159 human study participants (total 275 knees) with symptomatic OA of at least one knee.\u00a0 Knee OA severity was evaluated by early (EP) and late phase (LP) technetium-99m-methylene disphosphonate bone scintigraphy, and radiograph scored semi-quantitatively. Late phase whole body bone scintigraphy was scored semi-quantitatively for assessment of total body OA load.\u00a0 Correlations of biomarker levels and disease assessments utilized generalized estimating equations where appropriate.\u00a0 Principal components analysis was used to explore the contribution of each joint site to the variance in serum COMP.\u00a0\u00a0\u00a0 Results. The overall correlation of synovial fluid COMP and serum COMP was significant but modest (r value of 0.206, p value of 0.006).\u00a0 Synovial fluid COMP correlated most strongly with EP knee bone scans (p value of 0.0003) even accounting for OA severity by late phase bone scan (p value of 0.015), and SF volume (p value of less than 0.0001).\u00a0 Serum COMP correlated with total body bone scan score (r value of 0.188, p value of 0.018) and best reflected bone turnover in the shoulder, spine, lateral knee and sacroiliac joints.<span>\u00a0\u00a0 <\/span>Conclusion.\u00a0 Synovial fluid COMP correlated strongly with two indicators of knee joint inflammation, early phase bone scintigraphy and synovial fluid volume. This same biomarker measured in the serum correlated with total body measures of joint disease severity by late phase bone scintigraphy. In considering the ease with which bone scintigraphy is conducted, the adoption of this method for clinical use in the quantification of OA burden can be envisioned.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 14pt;\">Redox Regulation of RhoA<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Amir Aghajanian, Erika Wittchen, Sharon Campbell and Keith Burridge<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">The endothelial lining of the vasculature is a tightly regulated, selectively permeable barrier between blood and tissues. Junctions between endothelial cells are critical in the regulation of this permeability, modulating the passage of fluid, macromolecules, and leukocytes. Excessive vascular leakage is pathological as seen during inflammation, shock, and ischemia-reperfusion injury. Reactive oxygen species (ROS) increase endothelial permeability, which can be inhibited with free radical scavengers and antioxidants. We have shown that H2O2 increases permeability across a monolayer of human umbilical vein endothelial cells (HUVECs) using real-time electrical impedance measurements. RhoA and other members of the Rho family of small GTPases are critical factors in the regulation of endothelial permeability because of their role in cytoskeletal and junctional reorganization; intriguingly, RhoA has recently been shown to contain two redox reactive cysteines within the phosphoryl-binding loop (C16 and C20). We hypothesize that ROS may influence endothelial permeability by directly affecting the activity of RhoA via modification of these cysteine residues. In agreement with this, exogenous treatment with H2O2 induces a concentration-dependent biphasic activation\/inactivation of RhoA in both HUVECs and HeLa cells. We show that mutant RhoA containing cysteine to alanine substitutions at C16 and C20 (C16A\/C20A) is not susceptible to the effects of H2O2 treatment when expressed in HeLa cells. We tested the significance of this by analyzing cell spreading on fibronectin, which normally requires a transient decrease in RhoA activity. Efficient cell spreading on fibronectin is limited when HeLa cells are treated with N-acetylcysteine, a radical scavenger. Similarly, cells expressing C16A\/C20A RhoA spread to a lesser extent than cells expressing wildtype-RhoA, presumably due to the mutant\u2019s resistance to modification by redox agents. These results suggest a novel, redox-based mechanism of regulating RhoA activity, which may have a role in the modulation of vascular permeability.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Endothelian antagonists lead to alterations in both breast cancer and bone metastases<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Didier Dreau, Heather Wyan, Lauren D. Allen, Mark G. Clemens<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">We investigated the effect of various endothelian-1 antagonists on the angiogenesis associated with breast cancer growth and development of bone metastases. Murine mammary carcinoma 4T1 cells were injected in a skin-fold chamber implanted with bone explants on immunocompetent CB6 mice. Mice were treated with or without various antagonists of either ETRA, ETRB, or both ET-1 receptors. The progression of the vascularization within the chamber was monitored over time by intravital microscopy (IVM). The development of bone metastases was assessed by histological studies and the presence of cytokeratin-19 in bone explants. In addition, mRNA and protein expressions of endothelians, VEGF, and their receptors were evaluated in both tumor and bone metastases. Results indicate that only some of the ET-1 antagonist treatments tested were associated with significantly reduced tumor mass and tumor bone metastases. Decreased vessel numbers were observed in both tumor and bone explants following treatment with efficient ET-1 antagonists (p<0.05). mRNA and protein expressions for ETRA, ETRB, and VEGFR2 were decreased in the tumor mass of treated animals compared to control mice (p<0.05). These changes were correlated with smaller tumor masses and reduced bone invasion (p<0.05). Our data support the hypothesis that ET-1 through its receptors may play a key role in the angiogenesis associated with the development of breast metastases to bone. <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Cardiac Risk and Knowledge of Risk Factors in Patients Presenting to the Cardiac Catheterization or Cardiac CT Labs<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">James Barnwell,\u00a0Larry Klein MD, Mike Gillespie MD, Eric Yang MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background:\u00a0The dilemma of cardiovascular risk assessment has resulted in screening tools such as the Framingham Risk Calculator and the NCEP guidelines for risk appraisal.\u00a0However, the effectiveness of these evaluations hinges on the patient\u2019s perception of self risk in comparison to what is being quoted to them.\u00a0The purpose of this study is to explore patient knowledge and understanding of cardiac risk analysis and to evaluate the possible disconnect between a patient\u2019s views of self risk with that of their physician.\u00a0\u00a0 Methods and Results:\u00a0Three hundred and twenty two patients undergoing Cardiac Catheterization or CT cardiac imaging were divided into recurrent cardiac event and initial cardiac presentation.\u00a0All patients\u2019 with an obtainable lipid panel received a 10 year risk calculation using the NCEP\u2019s guidelines. The outcomes of this calculation stratified our patients into low, medium, and high risk.\u00a0Of the 322 patients screened, 147 were presenting with their first cardiac event, 110 agreed to answer a questionnaire, and 93 of those questioned had an obtainable lipid panel and a diagnostic cardiac study.\u00a0The results were: 27% recalled a physician estimating their cardiac risk, 55% had an incorrect self risk assessment in comparison to Framingham, 65% stated that they would have made lifestyle changes following a physician statement of cardiac risk, 85% stated they would have made lifestyle changes following an imaging study, and 68% commented that they would put more effort into life style changes following a positive imaging technique as opposed to physician verbal warning.\u00a0\u00a0 Conclusion:\u00a0Our study demonstrated that a significant portion of our patient population could not recall receiving a cardiac risk assessment from a physician.\u00a0Of those that did receive this evaluation, there was a significant discord between patient self risk assessment and that of their physician.\u00a0Patients with this disparity retrospectively believed they may have altered their risk patterns with further imaging to correct this disbelief.\u00a0\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Parental Literacy and Pediatric Peritoneal Dialysis Outcomes<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Michael J Belsante, BSE, Otis Burnett, BS, Darren DeWalt, MD, MPH, Phil Icard, MS, Debbie Gipson, MD, MSPH, William Primack, MD, David Tauer, RN, Hyunsook Chin, MPH, Paul Fields, BS, BA, Kristi Bickford, BA and Maria Ferris, MD, MPH, PhD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Purpose: To correlate parental literacy scores with health outcomes amongst pediatric peritoneal dialysis (PD) patients.\u00a0\u00a0 Methods: Literacy scores of the parents (n=34) of children previously or currently receiving PD were assessed using the Word Reading subtest of the Wechsler Individual Achievement Test (WIAT) II, an individually administered test, which provides standardized subsets and composite scores (M=100; SD =15). A parental survey and chart review for the children ascertained health outcomes including peritonitis rates, adherence to treatment and emergency department (ED) visits.\u00a0Results: Parental mean age was 40 years (range = 21-77). Mean parental literacy score was 85.3. The median score for the cohort was 90. White (n=10) parents had higher mean literacy scores than Black (n=20) parents (p<.01). Children of parents who had standard literacy scores less than 90 had more episodes of peritonitis per patient month than those whose parent had a higher score. Low literacy is associated with low adherence to treatment whereas ED visits did not correlate with literacy scores.\u00a0Conclusion: PD patients whose parents have lower literacy scores have significantly more peritonitis episodes and poorer adherence to treatment than patients whose parents have higher literacy scores.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Parasite Burden and IBS: A Case Control Study<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Matthew Benshoff, Loreto Cortes, MD, Douglas Morgan, MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Objective: To determine if intestinal parasite presence is correlated to increased incidence of irritable bowel syndrome (IBS) in a non-sterile environment using a case-control study.\u00a0\u00a0\u00a0\u00a0\u00a0 Methods: The study was conducted using the existing nested case-control component\u00a0(N=379) of a cross-sectional survey (N=1,642) of the inhabitants of Leon, Nicaragua. The cases were selected using the Rome II Modular Questionnaire followed by physician confirmation. The controls were selected at random from FGID-negative subjects. Stool samples from the case-control group were analyzed for parasite presence and type. Data were analyzed using SPSS statistical software and chi-squared tests were employed to determine statistical significance of relationships.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Results: A nested case-control population (N=357) had an (incidence) prevalence of intestinal parasite carriage of 16% (N=57) with 17% of cases and 15% of controls testing positive for intestinal parasites.\u00a0There was no correlation found between parasite carriage and IBS incidence among the sample population (OR=1.09, 95% CI=0.62-1.91).\u00a0Additionally, no individual parasite was found to increase the risk of IBS.\u00a0\u00a0\u00a0\u00a0\u00a0 Conclusion: While parasite infection has been associated with post infectious IBS in sterile environments, there is no statistically significant relationship between parasite carriage and IBS incidence in the developing nation environment of Leon, Nicaragua.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Effectiveness of Manipulating Arachidonic Acid Metabolism in Healing Fracture Nonunions<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Berry<\/span><span style=\"font-size: 10pt;\">, John, Daniel Cavanaugh, Paul Weinhold, PhD, Laurence E. Dahners, MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">The American Academy of Orthopaedic Surgeons defines a fracture nonunion as one which has not healed for three months and shows no promise of healing.\u00a0\u00a0 The two of the most effective treatment options are surgical repair of the fracture and treatment with Levodopa (L-Dopa).\u00a0Surgical repair of a fracture nonunion is both invasive and expensive.\u00a0However, surgery presents a high success rate (80-90%) of uniting and repairing a fracture.\u00a0Merck and Company have stopped producing L-Dopa in favor of Sinemet, a combination of L-Dopa and Carbidopa.<span>\u00a0\u00a0 <\/span>Carbidopa is useful in the treatment of Parkinson\u2019s because it reduces the side effects of L-Dopa.\u00a0\u00a0 In the case of fracture nonunions, Costa et al found Sinemet was not as effective healing fractures as L-Dopa.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Genetic knockout experiments have provided evidence that bone growth can be stimulated through manipulation of arachidonic acid metabolism.\u00a0Additionally, Lovastatin has been shown to be effective in stimulating bone growth when the local concentration is kept high enough on the fracture site.\u00a0We evaluated three drugs, zileuton, montelukast sodium, and lovastatin in healing nonunion fractures.\u00a0After obtaining IACUC approval, the rats underwent an operation under 2.0-3.0% isoflurane anesthesia.\u00a0The operation exposed the right femur with then stripped the bone of its periosteum then filed a notch until the bone may be easily broken transversely through the the diaphysis.\u00a0Omega pins were inserted into the two ends of the fracture. The loop created a fracture nonunion of 1-2 mm. The wound was closed using a subdermal stitch.\u00a0\u00a0\u00a0\u00a0 Rats were given zileuton and montelukast sodium in chow while lovastatin was injected at the fracture site.\u00a0The rats were X-Rayed at 3, 4, and 5 weeks then sacrificed at 5 weeks. Stress testing shows that montelukast sodium improved over control, lovastatin did not make a difference and zileuton actually impaired healing.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Regulation of Cathepsin L by the Serpin Protein C Inhibitor<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Ryan Bialas, Yolanda Fortenberry<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Protein C inhibitor (PCI) is a plasma serine protease inhibitor (serpin) that regulates several serine proteases in coagulation and fibrinolysis including thrombin and activated protein C (APC). The cysteine protease, cathepsin L, has been shown to play a role in many physiological processes including cardiovascular disease and tumor cell invasion. Recently, several serpins have been described to inhibit serine and cysteine proteases, termed cross-class inhibitors. The goal of this project was to determine if PCI inhibits cathepsin L activity and if so, does this inhibition process mimic the mechanism of serine proteases. Studies have shown that the prototypical serpin, antithrombin (AT), inhibits the cysteine protease cathepsin L. We found that PCI is a more efficient inhibitor of cathepsin L than AT with an inhibition rate (k2) of 1.5 x 106 M-1min-1 compared to 5.2 x 104 M-1min-1 for AT. Also, PCI is a more efficient inhibitor of cathepsin L than either thrombin or APC whose inhibition rates are 5.7 x 105 M-1min-1 and 3.4 x 104 M-1min-1, respectively. Interestingly, a reactive site P1 mutant (R354A) of PCI does not inhibit thrombin but does inhibit cathepsin L at rates comparable to wild-type PCI. This implies that the P1 residue of PCI does not determine specificity for inhibition of cathepsin L unlike for thrombin and APC. We believe that the specificity is primarily determined by the hydrophobic Phe residue located at the P2 position since other serpins that inhibit cathepsin L contain either a Phe or Val at the P2 position. The wild-type PCI-cathepsin L interaction has a stoichiometry of inhibition (SI) value of 1.6. This indicates that PCI is an effective and possibly a physiologically relevant inhibitor of cathepsin L. Regulating cathepsin L by serpins like PCI may be a novel and new pathway of regulation of hemostasis-thrombosis and metastatic diseases.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Antimicrobial treatment in the postoperative care of neonates with severe necrotizing enterocolitis<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Jason Blatt, J. Duncan Phillips MD<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background\u00a0&#8221; &#8220;Necrotizing Enterocolitis is a common disease of prematurity, which causes severe inflammation of the GI tract.\u00a0Severe cases require resection of necrotic bowel or peritoneal drainage.\u00a0The post-operative care these patients is poorly described; management is based on the subjective judgments of the responsible physicians.\u00a0\u00a0 Current care for surgical NEC includes heavy antimicrobial therapy for extended periods, exposing patients to superinfection.\u00a0Studies of wound infection comparing neonates to older children have found no increased incidence of infection, suggesting that extended prophylaxis may be unnecessary.\u00a0\u00a0\u00a0 Aims\u00a0&#8221; We will determine whether patient outcomes are significantly influenced by antimicrobial choice and duration in postoperative NEC neonates.\u00a0It may be possible to elucidate certain subgroups of patients that benefit from more intensive therapy.\u00a0\u00a0\u00a0\u00a0 Methods\u00a0\u00a0 &#8220;Data was collected on the last 109 patients who underwent surgery for NEC or perforation at UNC.\u00a0Numerous variables were recorded from the medical charts of these infants. Statistical tests will be used to examine how antimicrobial treatment times affected survival rates and morbidity at 30, 60, and 90 days.\u00a0\u00a0\u00a0 Results\u00a0&#8221; &#8220;Much data remains to be collected in this study.\u00a0However, we have made a number of interesting observations with the data we do have:\u00a01)&#8221; 90% of neonates with peritoneal drains at UNC require subsequent laparotomy.\u00a0This is a much higher rate of secondary laparotomy than at other institutions.\u00a0\u00a0\u00a0 2) Surgical NEC at UNC has a 38% mortality.\u00a0Despite our best efforts this remains a dire illness.\u00a03) &#8220;57% of babies who die from surgical NEC have pan-necrosis of the bowel on exploration.\u00a0Since NEC is poorly understood, we must consider whether operating sooner may arrest the necrosis before it reaches a fatal extent.<span>\u00a0\u00a0\u00a0 <\/span>Discussion\u00a0&#8221; &#8220;The data collected thus far has armed our pediatric surgery team with new knowledge about NEC and its consequences.\u00a0They are better able to council families now that they know the mortality rate of surgical NEC.\u00a0We are identifying factors allow surgeons to identify better surgical candidates, and are reconsidering peritoneal drain placement strategies.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Comparison of Catheter-Based Radiofrequency Ablation and Photodynamic Therapy for Barrett\u2019s Esophagus<\/span><\/p>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Joseph M. Bumgarner, Millie D. Long M.D., Nicholas J. Shaheen M.D., M.P.H.<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Two novel modalities for the treatment of Barrett\u2019s esophagus (BE) are currently commercially available.\u00a0These include catheter-based radiofrequency ablation (RFA) and photodynamic therapy (PDT).\u00a0\u00a0\u00a0 Objectives: We aimed to evaluate outcomes of % remaining BE after initial treatment, cure of dysplasia over treatment course, and\u00a0stricture formation in patients with BE undergoing either RFA or PDT.\u00a0\u00a0\u00a0\u00a0\u00a0 Methods: A chart review of patients with BE was performed at two tertiary referral centers. Patient characteristics and procedure specific data were abstracted. Bivariate analyses comparing ablation type to each outcome were performed; Wilcoxon rank-sum or chi square test statistics were used as appropriate. Multivariable logistic regression models were used to assess each outcome controlling for potential covariates. Variables were dropped from the models based on change in beta coefficients using a backwards elimination approach.<span>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>Results: 225 patients were assessed (103 RFA, 122 PDT).\u00a0The majority of the patients were male and in their 60\u2019s.\u00a0The median % remaining BE after the initial procedure was 20%.\u00a0On bivariate analysis, the median % remaining was 15% vs. 30% for RFA vs. PDT (p=0.40). There were a total of 18 strictures (12%) in 145 patients undergoing repeat endoscopy.\u00a0Of patients with RFA as the initial modality, significantly fewer had a stricture complication compared to patients undergoing PDT (p=0.05). On multivariate analysis, the odds of stricture was lower with RFA as compared to PDT (OR 0.29, 95% CI 0.09-0.95).\u00a0On multivariate analysis the odds of cure of dysplasia for RFA was not different when compared to PDT (OR 0.69, 95% CI 0.26-1.85).\u00a0\u00a0\u00a0 Conclusions: RFA therapy is associated with significantly fewer stricture complications as compared to PDT.\u00a0There is no difference between the modalities for either % remaining Barrett\u2019s after initial endoscopy or cure of dysplasia.\u00a0These results may impact choice of ablation technique in patients with BE.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">A Comparison of Systemically and\/or Locally Applied Antibiotics for Surgical Infection Prophylaxis: An in vivo study<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Daniel L. Cavanaugh, John Berry, Seth R. Yarboro, and Laurence E. Dahners<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background<span>\u00a0\u00a0\u00a0 <\/span>Prophylactic systemic antibiotics significantly lower the risk of postoperative infection. In a previous study from this laboratory injection of antibiotics directly into the wound cavity was even more effective. In this study, we investigated the efficacy of direct antibiotic injection into a wound cavity after wound closure, alone and in combination with systemic antibiotics. We hypothesized that a combination of preoperative systemic administration and postoperative local injection would be the most effective.\u00a0\u00a0\u00a0 <br \/> Methods\u00a0\u00a0\u00a0 Rats were divided into six treatment groups: no treatment, local gentamicin, systemic cefazolin, local cefazolin, local gentamicin\u00a0\u00a0 systemic cefazolin, and local cefazolin\u00a0\u00a0 systemic cefazolin. A wound cavity was opened along the femur, a cerclage was placed and 2.5 x 108 CFUs of S. aureus was inoculated. Systemic antibiotics were injected subcutaneously 30 minutes before initial incision. Local antibiotics were injected percutaneously into the wound cavity after closure. Rats were sacrificed at 48 hours postoperatively and quantitative cultures obtained.\u00a0\u00a0 <br \/> Results:\u00a0All groups receiving antibiotics showed significantly lower bacterial counts than the no treatment control (p < 0.001). Local gentamicin treatment decreased CFU isolates by approximately two orders of magnitude over systemic cefazolin (p = 0.00005) and five orders of magnitude over the control (p = 0.00003). The combination of local gentamicin and systemic cefazolin decreased bacterial counts by approximately seven orders of magnitude over the no treatment control group and provided a statistically significant improvement over local gentamicin alone (p = 0.00006). <br \/> Conclusions:\u00a0In support of our hypothesis, the combination of systemic cefazolin and local gentamicin proved the most effective regimen. Local injection of gentamicin again proved more effective than systemic administration of cefazolin but did not perform as well as the combination treatment of both antibiotics. The initially high concentrations of locally applied antibiotic and the utilization of two different antibiotic classes may have contributed to the observed efficacy.<br \/> Clinical Relevance: If this work is supported by clinical trials such a treatment could prove valuable as a regimen for prophylaxis of surgical wound infection.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Does the murine formyl peptide receptor play a role in LPS signaling?<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Rebecca Chasnovitz, Ji-Liang Gao, Phil Murphy<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><strong><span style=\"font-size: 10pt;\">Background<\/span><\/strong><span style=\"font-size: 10pt;\">: Lipopolysaccharide (LPS), or bacterial endotoxin, is a major mediator of septic shock, a rare life-threatening complication of bacterial infection. Determinants of fatal outcome in septic shock are poorly understood.\u00a0 Since neutrophils normally control bacterial infection, and since the formyl peptide receptor (Fpr) is a major neutrophil chemoattractant receptor, we asked whether this receptor was important in septic shock.\u00a0<strong>Hypothesis<\/strong>: Fpr regulates pathogenesis of septic shock.\u00a0<strong>Design<\/strong>: Fpr-\/- and WT mice were injected with 200 mg LPS iv. We observed the mice clinically for 7 days and measured serum levels of lps and the inflammatory cytokines TNF\u03b1, IL-6, IL-1\u03b1, and IL-1\u03b2 at 1, 2, 4.5, 8, 13.5, and 23.5 h after lps challenge. Neutrophils elicited by thioglycollate installation ip were harvested from Fpr-\/- and WT mice and Ca++ flux was measured in response to lps.\u00a0<strong>Results<\/strong>: After lps injection, Fpr-\/- mice experienced markedly increased mortality compared to WT mice (50% v 7%, p<0.005). This was associated with increased serum concentration of lps 13.5 h after injection (p=0.0105), and higher concentration of all four inflammatory cytokines tested 13.5 and 23.5 h after injection. LPS induced a rapid and transient flux of intracellular Ca++ in neutrophils from WT mice ex vivo that was reduced by 69% in neutrophils from Fpr-\/- mice.\u00a0<strong>Conclusion<\/strong>: Fpr protects against fatal outcome after lps injection of mice. The mechanism may involve accelerated lps clearance and reduced production and\/or accelerated clearance of inflammatory cytokines.\u00a0 Our preliminary data indicate that lps may be a direct agonist at neutrophil Fpr.\u00a0 We speculate that lps-Fpr interaction may induce internalization and clearance of lps by neutrophils.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Use of three-dimensional chest wall imaging in the evaluation and management of complex pediatric chest wall disorders<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Ali Chhotani and J. Duncan Phillips, MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Chest wall deformities are often identified in infancy, but patients normally do not become symptomatic until adolescence.\u00a0Symptoms can include dyspnea with mild exertion, pain in the anterior chest, and palpitations.\u00a0Stroke volume, cardiac output, and lung expansion may also be reduced.\u00a0Repair of the defect is typically recommended for patients who are symptomatic or have a relatively severe defect.\u00a0Modern surgical repair of pediatric chest wall deformities began in the early 1950\u2019s with the description of the so-called \u201cRavitch procedure.\u201d\u00a0Currently numerous surgical procedures exist that correct the complications of older procedures or avoid the complications altogether to improve patient outcomes.\u00a0The procedure used depends largely upon the characteristics of the deformity.\u00a0To help characterize the deformity, surgeons are using three-dimensional imaging.\u00a0It remains unclear, however, which subgroups of chest wall deformity patients benefit from three-dimensional imaging and how exactly that information may alter surgical planning.\u00a0\u00a0 Data was collected on patients in which a CT scan performed and interpreted at UNC between 2001-2006 to characterize their chest deformity.\u00a0A total of 67 patients met all the inclusion criteria.\u00a0Preliminary results indicate that the control arm of the study (CT imaging without 3D reconstruciton) is too small for reliable statistical analysis.\u00a0The experimental arm of the study (CT imaging with 3D reconstruction) shows that while the use of 3D imaging has increased since 2001, there was a period in the intervening years when the technology appears to have been used less by the UNC surgeons.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Antimicrobial Susceptibility Surveillance and\u00a0Development of Algorithms for Clinical Management at Kamuzu Central Hospital in Lilongwe, Malawi<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Rushina Cholera, Gabriel Malunga, Debbie Kamwendo, Mina Hosseinipour, Bill Miller, Mwai Makoka,\u00a0Peter Gilligan, Irving Hoffman<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Infectious diseases are a major part of clinical practice in the developing world. Various antimicrobial agents are used alone or in various combinations to treat these infections. However, over time, many microorganisms develop resistance to these antimicrobial drugs. In the developed world, real-time determination of antimicrobial susceptibility is used to guide therapeutic decisions. In contrast, most resource-poor countries cannot provide such real-time support and instead broad spectrum antimicrobial therapy is initiated empirically, based on clinical observation and patient histories. This is undesirable, as empiric and broad spectrum antibiotic use is a major factor in the emergence of antibiotic resistance and as a result, clinical care is algorithm driven. The UNC Microbiology Survey at the UNC Project in Lilongwe, Malawi has two major goals: to characterize the antibiotic drug resistance patterns at Kamuzu Central Hospital (KCH) and to use this information along with clinical data to design updated algorithms for patient care. This type of information is collected and used regularly in the United States but has not been collected in Malawi for years.\u00a0This project is currently in its final stages and should be completed by December 2007.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Cardiovascular Risk Factors in Rural Mexico: Results from the Proyecto Puentes de Salud<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">CR Clover, KA Olson, LA Temming, MG Cohen<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background\u00a0\u00a0 Hispanics are the largest and fastest growing minority in the United States (U.S.), with Mexicans being the largest Hispanic subgroup. However, little is known about their antecedent health risks and how these risks contribute to their health when they immigrate to the U.S. The primary purpose of this study was to begin evaluating the cardiovascular (CV) risk in Mexicans who live in high migration areas of Mexico in order to better understand the health of immigrant Mexicans. Furthermore, because our studies took place in high migration areas, we looked to see if the migration of relatives to the US leads to a change in CV risk.<span>\u00a0\u00a0\u00a0 <\/span>Methods\u00a0Participants were recruited from 15 rural communities in Guanajuato, Mexico. Participants were screened for hypercholesterolemia, impaired glucose tolerance, elevated blood pressure, abdominal obesity, and low HDL cholesterol. Participants were also interviewed regarding their past medical history, lifestyle behaviors, and social factors.<span>\u00a0\u00a0\u00a0 <\/span>Results\u00a0\u00a0 A total of 699 participants were screened. Prevalence of elevated blood pressure was 35.6%, and 22.5% of the sample had impaired glucose tolerance. Frequency of hypercholesterolemia was 18.3% and frequency of low HDL was 82.5%. Abdominal obesity was present in 78.6% of subjects. Of note, 39.6% met modified ATP III criteria for metabolic syndrome. Although we found high rates of CV risk, we found no statistically significant relationship between having a relative in the U.S. and increased CV risk.\u00a0\u00a0\u00a0\u00a0 Conclusions\u00a0\u00a0 Our study shows a high prevalence of cardiovascular risk in rural Mexicans. The prevalence of metabolic syndrome and of low HDL cholesterol levels was particularly noteworthy in this young cohort. Future research may focus on the role of lack of health-literacy in perpetuating poor diet and limited exercise. Improving the health of Mexicans in their place of origin may improve the health of Latin American immigrants to other nations.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Corpus Callosum and Lateralized or Asymmetric Brain Hemisphere Function in Subjects at High Risk for Schizophrenia<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Asa L. Cordle, Ayseil Belger, PhD, Martin Styner, PhD, Robert K. McClure, MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">The corpus callosum is an anatomical substrate for inter-hemispheric communication.\u00a0Both first-episode and chronic schizophrenic patients have exhibited structural changes in the corpus callosum.\u00a0Disturbance in normally lateralized or asymmetric functions across brain hemispheres are currently being investigated in schizophrenia.\u00a0If such a disturbance is the result of developmental defects beginning in adolescence or earlier, then differences should be evident in subjects at high risk of developing the disease.\u00a0DTI and MRI from 26 at risk subjects are being analyzed with a probabilistic tractography model to identify corpus callosum subdivisions connecting to individual cerebral lobes.\u00a0\u00a0 Previous approaches use arbitrary geometric subdivisions.\u00a0Design fluency and verbal fluency tasks were completed in the high-risk subjects as functional testing.\u00a0Correlation between functional testing performance, corpus callosum subdivision size, and cortical white matter changes are being investigated.\u00a0The statistical analysis of this data is in progress at the time this abstract was submitted.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">CHOLESTEROL SCREENING DOES NOT MOTIVATE OBESE ADOLESCENTS TO DECREASE THEIR BMI<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Nipa Doshi BSPH, Eliana M. Perrin MD, MPH, Denise Esserman PhD, Michael J. Steiner MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><strong><span style=\"font-size: 10pt;\">Purpose:<\/span><\/strong><span style=\"font-size: 10pt;\"> The utility of routine cholesterol screening in obese adolescents is controversial.\u00a0Proponents argue that in addition to detecting potential lipid abnormalities, routine screening may help motivate obese patients to decrease their BMI by reinforcing high physician concern regarding patients\u2019 weight. We sought to determine the effect of cholesterol screening on subsequent BMI change in obese adolescents.\u00a0<strong>Methods:<\/strong> We performed a retrospective cohort study of overweight youth (BMI > 85% on CDC standardized growth charts) aged 10-18 who attended a well child visit in a general pediatric clinic at an academic medical center.<span>\u00a0\u00a0 <\/span>Patients who had a cholesterol screening performed between June 2004- June 2005 were individually matched based on age, gender, ethnicity, and BMI at baseline to patients who did not have the \u201cexposure\u201d of cholesterol screening. Subjects in both groups were followed for a minimum of 3 months and up to 2.5 years for change in BMI from baseline; our primary outcome variable. In addition to the BMI change difference, we also decided <em>a priori<\/em> to compare BMI trajectory between groups. We used t-test analysis for comparison of the mean changes between groups and a linear mixed model to compare BMI trajectories after exposure.\u00a0<strong>Results:\u00a0<\/strong>Twenty-four matched pairs met inclusion criteria for enrollment in the study (n=48).\u00a0Subject characteristics of matched pairs were as follows: 50% were female; 66% were African American and 8% were Latino; baseline BMI ranged from 26 to 46.\u00a0Comparing the means of best individual BMI change within each group over time, the screened group did not decrease BMI more than unscreened subjects (mean BMI change, -0.04, sd=1.8 and -0.99, sd=3.3 respectively, p=0.24).\u00a0Using a linear mixed model, screened children actually had an increase in BMI of 0.81 units per year of follow-up, while the matched controls decreased their BMI by an average of 0.44 units per year (p=0.053).\u00a0In exploratory subgroup analysis, there was no difference in BMI trajectory between those with normal cholesterol screening results and those with abnormal results (p=0.91).\u00a0<strong>Conclusion:\u00a0<\/strong>Cholesterol screening of obese adolescents does not appear to positively impact short term BMI change.\u00a0The trend of increased BMI in the screened group raises the possibility that screening may somehow \u201cdemotivate\u201d adolescents from making important weight changes. While further confirmatory research is necessary, the results of this study suggest that\u00a0cholesterol screening should not be undertaken solely to motivate children to lose weight.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">LPS preconditioning and its effects on oligodendrocyte precursors and neonatal white matter disease<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Courtney Failor, Dr. Wayne Price<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Inflammation is one of the proposed major etiologic factors influencing the development of white matter damage (WMD) in premature infants.\u00a0However, recent clinical studies have found that prenatally, low levels of inflammation are protective, while more significant chorioamnionitis predisposes the preterm infant to WMD.\u00a0Inflammatory injury to precursor oligodendrocytes (preOLs) is thought to be a key event, as loss of these cells disrupts further OL development and results in impaired myelination; part of the pathophysiology of WMD in these patients.\u00a0Mice at post natal days 1-5 were chosen for this study due to the correspondence of abundance preOLs during this time and their correspondence to the \u201chigh risk\u201d period for WMD in preterm infants.\u00a0\u00a0\u00a0\u00a0\u00a0 To investigate the protective nature of inflammation, a sensitizing dose of LPS was administered prior to induction of inflammatory injury via a second injection of LPS on PND 4.\u00a0We evaluated the effect of varying the time interval (6 h vs. 24 h) between the first and second doses of LPS and the outcome was assessed by direct quantitation of MBP staining of OL cells in the cortex and caudate-putamen regions at PND 10.\u00a0Based on these results, we found that LPS enhanced brain injury when administered 6 h before the second injection; a so called sensitizing effect.\u00a0Conversely, brain injury was significantly decreased at the 24 h interval.\u00a0Elucidating the mechanisms behind this possible neuro-protective effect holds significant implications for understanding the development and possible prevention of WMD.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Conformational Restraints on Reactivity of Human PR3-Specific Autoantibodies Facilitated through Protein Folding Manipulations<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Lila Farrag, Ronald J. Falk<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Proteinase 3 (PR3)-specific antineutrophil cytoplasmic autoantibodies (PR3-ANCA) recognize conformational epitopes on PR3. This study evaluates PR3-ANCA target epitopes utilizing a novel recombinant PR3 (rPR3) produced to accommodate manipulations of the N-terminal domain. The rPR3 molecule contains an N-terminus six histidine tag, which can be removed by enterokinase (EK) cleavage of an adjacent EK cleavage site. Once cleaved the remaining amino acids correspond to the mature N-terminus of PR3. This rPR3 can be manipulated to produce three variant forms: tagged rPR3+his, EK-cleaved (his-tag removed) rPR3-his, and EK-cleaved, denatured\/refolded rPR3-his\/dr (the proteolytically active form). Patients with clinically positive PR3-ANCA titers (n = 40) were confirmed for reactivity against purchased native PR3 in our system. Controls included 29 healthy volunteers and 34 MPO-ANCA patients. All PR3-ANCA sera samples tested were reactive with one or more forms of the recombinant protein (greater than mean ELISA OD 405 + 2 SDs of controls). Of significance, three sera were reactive with non-active forms only and three others were more reactive with rPR3-his\/dr than with native PR3. The results of our evaluation of PR3-ANCA sera for reactivity against the three forms of our rPR3 protein uniquely exemplify the diverse array of epitopes within the PR3-ANCA population. This new recombinant form of PR3 should provide a suitable approach to mapping ANCA epitopes using site-directed mutagenesis.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Does Recreational Drug Use in Elderly Drivers Impact Mortality?<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Justin Fender, Anthony Charles, Sharon Schiro, Annabelle Fonseca, Howard Chen<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background:\u00a0The correlation between substance use in the elderly trauma patient and increased morbidity and mortality is as of yet undetermined.\u00a0Aims:\u00a0The primary goal of my research was to examine the relationship between recreational drug use and outcome in the elderly driver.\u00a0Methods:\u00a0The North Carolina Trauma Registry (NCTR) was queried to identify elderly trauma patients, over 65 years old, presenting to a trauma center over a 6-year period from January 2000 to December 2005.\u00a0Using SAS statistical software, patients with detectable levels of ethanol or illicit drugs were compared to those with no evidence of substance use.\u00a0Logistic regression analysis was used to model outcomes as predicted by several independent variables.\u00a0Co-morbidities were controlled for using the Charleson comorbidity index.\u00a0Results:\u00a0The data showed that out of 3481 trauma patients involved in a motor vehicle crash, 2987 patients were not tested for illicit drugs.\u00a0After controlling for injury severity score, age, gender, race, age, and Charleson comorbidity score, a positive screening for drugs, ethanol, or both was found to not predict mortality in drivers.\u00a0Conclusion:\u00a0The elderly trauma patient may also be predisposed to substance use and abuse, including prescription drugs that may result in cognitive impairment and diminished neuromotor response. Our study does not show worse outcome (mortality) in drug positive elderly drivers. However, screening rates in this subgroup of the population is low.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Malaria Care-Seeking Behaviors in Rural Ghana<\/span><\/p>\n<div>\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Kristine Folkerts<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Malaria is the leading cause of morbidity and mortality in Ghana. Significant barriers to the use of official sector health facilities exist, and thus many people rely on alternative treatments. An understanding of these activities at the local level is needed to inform policies aimed at reducing malaria\u2019s burden. There have been few studies on malaria care-seeking behaviors in Ghana\u2019s Central Region. Most studies in Ghana have not highlighted women\u2019s voices about the difficulties they face when caring for their children with malaria, nor have they presented mothers\u2019 suggestions for improvements. This study was designed to address these gaps in the existing literature. In-depth interviews were conducted with key informants and with twenty-four female caretakers of children under age five in four rural communities. The interviews addressed the women\u2019s perceived causes of malaria, the treatment activities they employed for the last illness episode in each of their children under age five, as well as their preferences, difficulties, and suggestions. Although two-thirds of the women implicated mosquitoes in the transmission of malaria, most cited additional erroneous causes. As expected, the women used a wide range of treatment activities, including home-based treatments, over-the-counter medications, consultations with herbal practitioners, and formal hospital\/clinic care. In almost half of cases, care-seeking behaviors included multiple treatments. Nearly a third of children received no antimalarial medications at their last episode. Of those children who were brought to the hospital\/clinic, their mothers waited an average of about five days before bringing them. The women identified poverty, poor education, and lack of transportation as significant barriers to the timely use of hospitals\/clinics. The results point to the continued need for education about the transmission and prevention of malaria, for campaigns to increase awareness in rural communities about Ghana\u2019s new malaria treatment guidelines, and for innovative initiatives to financially empower women. <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Identifying Nerve Fibers in Kidneys Using Laser Confocal Microscopy<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Nadezhda Gavrilova, Dr. Richard Bukoski<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">It has been shown that renal transplant patients develop hypertension over time. The mechanism may be connected with the loss of sensory neural innervation and especially with the loss of calcium-sensing receptors located on sensory nerves in transplanted kidney. They were shown causing reduction in blood pressure.\u00a0However, little is known of the sensory neural innervation within the kidney.\u00a0The performed study was designed to determine the nerve fiber distribution within the kidney. To determine the nerve fibers immunostaining of kidney slices with anti-CGRP (calcitonin gene related peptide), anti-NCAM (neural cell adhesion molecule) and anti-TH (tyrosine hydroxylase) followed by confocal microscopy visualization was performed. We detected red fluorescence, indicating nerve fibers, inside the kidney glomerulus, in Bowman\u2019s capsule, between and inside kidney tubuli. Our results confirm the possible role of sensory innervation in development of hypertension.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Referral Patterns and Patient Demand for Acupuncture Services at Kaiser Permanente Northwest<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Jason R Goldsmith, Charles Elder, Richard Hammerschlag, Remy Coeytaux<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Referral patterns and patient demand for acupuncture services at Kaiser Permanente Northwest\u00a0(KPNW) for a one- year period were collected and analyzed.\u00a0A combination of medical records and compiled data from KPNW and its outsourced self-referral network were filtered for all uses of the keyword acupuncture.\u00a0Chief complaint, frequency of use, and (in the case of the self referrals) range of clinical conditions was documented when available.\u00a0For the KPNW referrals, the data showed that the majority of referrals were for pain (78%) or neurological symptoms (11%).\u00a0For self referrals, the chief complaint was not obtainable, but the range of diagnoses treated was much larger than for doctor referrals.\u00a0The usage and demand patterns also differed between self- referrals and doctor referrals.\u00a0Self-referred patients averaged 6.5 visits\/year, compared to 7.4 among KPNW patients.\u00a0This difference is even greater when looking at only those KPNW patients in Washington state whose referrals were authorized, with a mean of 12.9 visits per year.\u00a0A mean of only 6 visits per year was observed among KPNW patients who were identified in their charts as requesting the referral.\u00a0These findings suggest that patients who manage their own care of acupuncture use it for a wider range of conditions, and that they seek fewer treatments compared to patients referred for acupuncture by physicians.\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Clinical Manifestations of Lactic Acidosis in Malawi<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Danica Gomes, Cecilia Kanyama, Mina Hosseinipour, George Joaki, Ralf Weigel, Nasinuku Saukila<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background\/Study Objectives\u00a0In Malawi, the first-line treatment for HIV\/AIDS is D4T\/3TC\/NVP.\u00a0It is a well-known fact that lactic acidosis is a major side effect of the Stavudine (D4T) drug and can be fatal if not addressed.\u00a0In resource poor Malawi, lactate laboratories are not readily available, thus it is imperative that we identify the features of lactic acidosis so that a clinical diagnosis can be confidently made based on presentation.\u00a0Our goal is to formulate a clinical criterion for lactic acidosis presentation in Malawi.\u00a0\u00a0\u00a0\u00a0\u00a0 Methods\u00a0Reviewed charts came from Lighthouse clinic (HIV clinic), Tidziwe center, and Kamuzu Central Hospital.\u00a0Tidziwe center, where UNC Project is based, represents the only location in Malawi that has the resources to do lactate labs.\u00a0We did a retrospective chart review of confirmed and suspected lactic acidosis cases.\u00a0Information such as demographics, antiretroviral history, signs and symptoms leading to suspicion of lactic acidosis, and lactate levels were recorded.\u00a0Confirmed lactic acidosis cases were dependent on symptoms and their resolution upon stopping ARVs or lactate levels greater than 3.5mmol\/liter.\u00a0Frequencies, means, medians and tests of associations were calculated.\u00a0\u00a0\u00a0\u00a0 Results\u00a0235 charts were reviewed.\u00a0120 were confirmed lactic acidosis cases.\u00a0115 were found not to have this diagnosis.\u00a0Among confirmed cases, median age was 39 years, median duration of ART was 439 days and the median increase in CD4 on ART was 183 cells.\u00a097% patients had gastrointestinal symptoms.\u00a093% had neuropathy, 72% had weight loss.\u00a0The mean lactate level was 6.5mmol\/L.\u00a07 patients were known to have died.\u00a0Among survivors maintained in care at the Lighthouse (69), 66% were switched to AZT\/3TC\/NVP.\u00a0Patients resumed ART after a mean of 79 days.\u00a0\u00a0\u00a0\u00a0\u00a0 Conclusion\u00a0Among confirmed cases, gastrointestinal symptoms accompanied by rapid weight loss and neuropathy or rapid progression of neuropathy supports a clinical diagnosis of lactic acidosis.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">The Designer GPCR: A new tool for selective modulation of signal-transduction pathways in vivo<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">John Hartmann, Atheir Abbas, Bryan Roth<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">\u00a0\u00a0\u00a0\u00a0 A novel approach to the study of G-protein coupled receptors (GPCRs) involves the development of \u201cdesigner\u201d receptors, or more specifically designer receptors exclusively activated by a designer drug (DREADD). For proof of concept, we worked with a human M3 muscarinic receptor (hM3), which had undergone directed evolution in yeast to be activated solely by the pharmacologically inert compound, clozapine-N-oxide (CNO). The DREADD is potently activated by CNO, but not by its endogenous ligand, acetylcholine (ACh), allowing selective activation of G-protein signaling in vivo. We created two lines of mice, an M3 DREADD transgenic with a tet response element (TRE) driving expression of an HA-tagged M3 DREADD, and another with the CamkIIalpha promoter driving tetracycline transactivator (tTA) expression. Thus, when the two lines are crossed, the HA-tagged M3 DREADD is expressed in CamkIIalpha-expressing neurons, which are primarily located in the hippocampus and cortex. Immunofluorescence using a mouse monoclonal anti-HA antibody provided initial verification of M3 DREADD expression in these regions. Furthermore, i.p. injection of CNO caused dramatic seizures in CamkIIalpha-tTA( \/-)\/M3 DREADD( \/-) mice, but causes no apparent behavioral effects in CamkIIalpha-tTA(-\/-)\/M3 DREADD( \/-) mice. Lastly, competition binding assays have confirmed the presence of two acetylcholine binding sites in double transgenic mice, owing to the expression of the normal M3 receptor and the M3 DREADD, each with a different affinity for ACh. This is in contrast to the wildtype mouse, which has only one binding site. Thus, we have demonstrated that modified GPCRs are suitable for in vivo studies. DREADD technology will prove to be a powerful tool for selective modulation of signal-transduction pathways, elucidating receptor-specific functions, and providing insight into disease states resulting from overstimulation of certain signaling pathways.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">The Effects of Leg Dominence and Strength Imbalance in the Kinematics of a Stop-Jump Task<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Daniel C. Herman, Andrea L. Moore, Anna R. Cruz, William E. Garrett, Bing Yu, Darin A. Padua<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">INTRODUCTION\u00a0Lower extremity strength imbalance has been shown to be possible risk factor for lower extremity athletic injury. The purpose of this study is to examine the effects of limb dominance and strength imbalances in the kinematics of female recreational athletes during a task often associated with anterior cruciate ligament injury.\u00a0\u00a0\u00a0 METHODS\u00a0Three cohorts were created, consisting of 1) subjects with at least 15% less strength in their gluteus medius (GMED) of their non-dominant (NDOM) limb compared to dominant (DOM); 2) subjects with at least 15% less strength in their quadriceps (QUAD) of their NDOM limb compared to DOM; and 3) subjects with less than a 10% strength imbalance between NDOM and DOM (NONE). Strength was assessed by hand-held dynamometry. The first 10 qualifying subjects for each group were selected for this study for 30 total subjects. GMED (age 22.5yrs, ht 1.67m, wt 62.2kg, ave. diff. 20%), QUAD (age 22.6yrs, ht 1.68m, wt 63.3kg, ave. diff. 23%), and NONE (age 21.4yrs, ht 1.65m, wt 58.4kg, ave. GMED diff. 3%, ave. QUAD diff. 3%).\u00a0\u00a0\u00a0 Lower extremity kinematics were collected during 5 stop-jump trials using three-dimensional videography. Dependent variables included knee valgus and flexion angles, and hip abduction and flexion angles. Statistical analyses were performed using a 3 [group] X 2 [limb] ANOVA (alpha<.05). Dependent samples t-tests were performed to investigate significant interactions.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>RESULTS\u00a0\u00a0 No significant main or interaction effects were observed in any of the dependent variables.\u00a0\u00a0\u00a0 SUMMARY\/CONCLUSIONS\u00a0The results indicate that lower extremity limb dominance and moderate lower extremity strength imbalances may not significantly alter athletic task performance in female recreational athletes, and thus may not be a significant risk factor for injury. Further study into larger strength imbalances and multi-muscle strength imbalances using prospective study designs, alternative athletic tasks, and larger sample sizes may be warranted.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Exploring the Relationship between Neutrophils and Cystic Fibrosis Biomarkers<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Chris Horvat and Charles Esther<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">BACKGROUND:\u00a0Adenyl purines are promising biomarkers of lung inflammation.\u00a0These compounds could be especially useful in studying and treating cystic fibrosis (CF), a disease characterized by repeated episodes of neutrophil-dominated inflammation that result in progressive lung failure.\u00a0\u00a0\u00a0 AIMS:\u00a0A biomarker must have a strong link to the relevant physiology.\u00a0This project begins to look at adenyl purine production by neutrophils, the hypothesized source of these biomarkers.\u00a0\u00a0\u00a0 METHODS:\u00a0Neutrophils were isolated from bronchoalveolar lavage (BAL) fluid and peripheral blood from patients with CF and healthy controls.\u00a0Purine production was subsequently measured at different incubation time points using etheno-derivitization and high proficiency liquid chromatography (HPLC).\u00a0\u00a0\u00a0\u00a0\u00a0 RESULTS:\u00a0Measurements of purine production by neutrophils revealed slight increases in adenosine and ADP, decreases in ATP, and significant increases in AMP over time.\u00a0\u00a0\u00a0 DISCUSSION:\u00a0An observed increase in AMP over time among isolated neutrophils is consistent with accounts of neutrophil purine metabolism in the literature.\u00a0High initial values of both AMP and ATP, as well as a sharp initial decline in ATP levels, suggest that premature activation of neutrophils occurred during the isolation protocol.\u00a0Our results are consistent with an initial burst of ATP, followed by ecto-ATPase metabolism to the associated metabolites (predominantly AMP).\u00a0Future goals of this work include enrolling more patients and collecting more BAL fluid and blood samples, as well as refining the neutrophil isolation protocol to prevent premature activation.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Prenatal Cocaine Exposure and Oxytocin: Social Behavior in Young Adult Male Rats<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Jarrett, T.M., McMurray, M.S., Walker, C.H., and Johns, J.M.<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Many rodent models of prenatal cocaine exposure document heightened levels of adult-social-aggressive behavior and differences in brain-oxytocin levels.\u00a0None of these models assess the impact of prenatal-cocaine-exposure combined with being reared by a cocaine-treated rat mother. Hypothesis: Male prenatal-cocaine exposed offspring reared by a cocaine-treated mother will exhibit more social aggression and have lower brain-oxytocin levels. Methods: Prenatal-cocaine-exposed offspring were cross-fostered at birth and reared by either cocaine-treated or control rat mothers. At 60 days of age male offspring were tested for unprovoked aggression and success in obtaining water in a social behavior task.\u00a0Results: Prenatal exposure to cocaine combined with rearing by cocaine treated dams, significantly increased aggressive behaviors such as threats and attacks and reduced success of attaining water.\u00a0Males reared by cocaine treated dams regardless of their prenatal exposure condition, had significantly reduced levels of amygdaloidal oxytocin following completion of the water competition task.\u00a0Conclusions: Prenatal-cocaine-exposed male offspring raised by a cocaine-treated mother are more socially aggressive and have lower brain-oxytocin levels.\u00a0Interestingly, they are also less successful in attaining water suggesting this model of prenatal-cocaine exposure and rearing by a cocaine-treated rat mother also induces maladaptive social behavior.\u00a0These studies were supported by NIH R01 grants DA -13283 and DA-13362 awarded to Dr. Johns. These data were first presented at the 2006 Annual Meeting of the International Society on Behavioral Neuroscience, Whistler, Canada.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Changing Indications for Revision Total Knee Arthroplasty<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Lachiewicz and Lachiewicz<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Introduction:\u00a0There is relatively little data on the indications for revision total knee arthroplasty (TKA).\u00a0Two previous studies have suggested that infection and loosening are the most common reason for failure. The purpose of this study was to determine if the indications for revision have changed over the past decade.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Methods:\u00a0This is a retrospective review of demographic data and the indications for revision TKA in two cohorts of patients performed 10 years apart by one surgeon at a university referral hospital.\u00a0Patient gender, age, weight, time in-situ and reason for revision (8 categories) were recorded and analyzed by chi-square tests.\u00a0The first cohort was 61 revisions performed between 1990 and 1997.\u00a0The second cohort was 96 revisions performed between 2000 and May 2007.<span>\u00a0\u00a0\u00a0 <\/span>Results:\u00a0There were significantly more male patients in the more recent cohort.\u00a0There was no significant difference in the mean age or weight (corrected for gender) between the cohorts.\u00a0There were significantly more revisions for instability and wear in the recent cohort. \u00a0There were significantly fewer revisions related to the patella prosthesis.\u00a0The leading cause for revision in both cohorts was still aseptic loosening of the components.\u00a0There was no significant change in the number of revisions for infection between the two cohorts.\u00a0\u00a0\u00a0 Discussion and conclusion:\u00a0The indications for revision total knee arthroplasty have changed significantly over the past decade.\u00a0More emphasis may be needed on proper balancing techniques to prevent instability and new bearing surfaces should be considered to decrease wear.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Reducing the Global Burden of Amebiasis: Investigations in Diagnosis, Treatment, and Prevention<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Rita Marie Lahlou<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">The burden of morbidity and mortality associated with diarrheal diseases presents a considerable challenge to health care providers, researchers, and policy makers, world-wide.\u00a0The infectious parasite, Entamoeba histolytica causes amebiasis, one form of diarrheal disease.\u00a0This thesis attempts to provide a comprehensive review of some of the current trends in research and clinical practices relating to the diagnosis, treatment and prevention of amebiasis infection.\u00a0Accurate and timely diagnosis of amebiasis is necessary for proper and effective treatment.\u00a0Unfortunately the current methods of diagnosis are not appropriate for the low-resource settings where amebiasis is most prevalent.\u00a0Consequently, a new, cost-effective, rapid diagnostic tool that detects antigen in stool specimens and antibody in serum samples was developed and verified through clinical trials in Dhaka, Bangladesh.\u00a0The device proved to be equally sensitive and specific for the diagnosis of infection with E. histolytica as traditional methods like ELISA and RT-PCR.\u00a0Histone deacetylase inhibitors are being explored as potential chemical therapies for persons suffering from amebiasis, as they cause cell cycle arrest and cell death. To determine the effects of HDAC inhibitors such as TSA and SAHA on E. histolytica, the growth rate, adherence capabilities, protein production, and HDAC activity of amoeba grown in the presence of inhibitors were measured using cell counting, CHO cell adherence assays, Western Blots and an HDAC activity assay kit.\u00a0The experimental results suggest a real potential for the use of HDAC inhibitors in treating amebiasis infections.\u00a0Finally, a brief overview of the promise and obstacles of preventative vaccine research for is presented.\u00a0An argument for increased funding and support for neglected tropical diseases is made, with the ideals of cost-effectiveness and setting-appropriateness in mind.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Effects of Cytochrome P450 Epoxygenase Overexpression on Lipopolysaccharide-Induced Cell Adhesion Molecule Expression in Murine Lung Endothelial Cells<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Garjae D. Lavien, Matthew L. Edin, Craig Lee, J. Alyce Bradbury, Laura M. DeGraff, Joan P. Graves and Darryl C. Zeldin<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Atherosclerosis represents the major cause of morbidity and mortality in developed countries. Lipopolysaccharide (LPS), a constituent of the outer membrane of gram-negative bacteria exhibits pro-inflammatory effects central to the etiology of atherosclerosis, such as upregulating endothelial selectin (E-Selectin), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) on the surface of endothelial cells. Epoxyeicosatrienoic acids (EETs), synthesized from arachidonic acid by cytochrome P450 epoxygenases CYP2J2 and CYP2C8, have anti-inflammatory properties. Exogenous administration of EETs reduces ICAM-1, VCAM-1 and E-selectin expression on endothelial cells.<span>\u00a0\u00a0 <\/span>\u00a0\u00a0Aim: Elucidate the role of overexpression of CYP2J2 and CYP2C8 in LPS-induced VCAM-1, ICAM-1 and E-selectin expression in murine lung endothelial cells (MLECs).\u00a0\u00a0\u00a0 Methods: MLECs were harvested from female mice with endothelial Tie2 promoter driven overexpression of CYP2J2 (2T HET) or CYP2C8 (8T HET), as well as their respective wild type littermates (2T WT, 8T WT). MLECs were cultured, grown to confluence, and incubated with either E. coli LPS or phosphate buffered solution (PBS) as a control for four hours. Cell lysis was followed by RNA extraction and reverse transcription. Real-time RT-PCR quantitation of VCAM-1, E-selectin, ICAM-1, CYP2J2, CYP2C8 and GAPDH were conducted on cDNA samples.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Results: Data from the real time RT-PCR indicates that 2T HET and 8T HET MLECs express CYP2J2 and CYP2C8 mRNAs, respectively whereas 2T WT and 8T WT MLECs do not. LPS increases VCAM-1, ICAM 1, and E-selectin RNA levels in all four cell lines compared to PBS in a dose-dependent fashion, which is consistent with previous studies. In comparison to 2T WT MLECs, preliminary data suggests that 2T HET MLECs have lower baseline mRNA levels of ICAM-1, VCAM-1, and E-selectin, as well as lower mRNA levels after LPS administration. In contrast, 8T HET MLECs did not show any differences in mRNA levels at the baseline or after LPS dosing compared to 8T WT MLECs.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Creating a Novel Nanofiber-based Epithelial Tissue Construct Using Human Umbilical Cord Blood Stem Cells<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Gita Madan, John van Aalst<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">The goal of our project is to culture umbilical cord blood (UCB)-derived stem cells on nanofiber scaffolds made of biodegradable polycaprolactone (PCL) with the intention of differentiating these stem cells into keratinocytes.\u00a0This stem cell based skin graft will not have the limitations seen in traditional cultured epithelial autografts (CEA):\u00a0these grafts take a considerable time to culture and are not clinically durable. The goal for the nanofiber-stem cell constructed skin will be quicker clinical availability and a skin graft that will have greater mechanical integrity,\u00a0\u00a0 Nanofibers can be used to create an ideal structure that can mimic the extracellular matrix (ECM) by providing a path for exchange of nutrients and metabolic waste between the scaffold and the environment. Nanofiber scaffolds have a higher rate of gas-exchange making them an ideal substrate for tissue culture.\u00a0Fibroblasts are initially seeded onto the nanofiber matrix, and the collagen secreted by the fibroblasts functions as a substrate for cell attachment and differentiation.\u00a0\u00a0\u00a0 Recent <em>in vitro <\/em>studies suggest that UCB stem cells can be differentiated into keratinocytes. Our aim is to differentiate CD34<sup>+<\/sup> hematopoietic stem cells derived from human umbilical cord blood into epidermal keratinocytes for <em>in vivo<\/em> studies on nanofiber mats.\u00a0In order to simulate the multistratified 3-dimensional structure of the skin <em>in vitro<\/em>, a method known as an organotypic culture is employed.\u00a0It is possible to get full differentiation of the keratinocytes <em>in vitro<\/em> into skin\u2019s component layers by simply raising the cell-layer to an air-liquid interface.\u00a0To date, our laboratory has successfully grown keratinocytes, fibroblasts and combinations of these cells on nanofiber scaffolds in preliminary steps of creating an organotypic model. \u00a0\u00a0In conclusion, our protocol describes a 3-dimensional organotypic tissue culture model to study the differentiation of human UCB stem cells into keratinocytes, creating a more robust skin substitute. <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Recreating breastfeeding as the normative feeding behavior: what are the risks associated with formula feeding?<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Melinda E. McNiel, Miriam H. Labbok<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">\u00a0Context:\u00a0The majority of studies published on the topic construct the data in a way that portrays formula-use as the standard behavior and exclusive breastfeeding merely as an ideal, associated with particular benefits.\u00a0In this secondary analysis we have converted odds and risks ratios so that the data reflects the risks of formula-use and normalizes exclusive breastfeeding.\u00a0The association between formula-use and increased risk for several adverse infant health outcomes is analyzed.\u00a0\u00a0 Objective: To normalize exclusive breastfeeding and establish formula-use as a risky behavior by converting data related to breastfeeding sensitive outcomes.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study Selection:\u00a0We referenced data primarily from the recently published, comprehensive AHRQ study on breastfeeding and maternal and infant health outcomes.\u00a0By using only studies including exclusive breastfeeding as a comparator group we limited the conditions to otitis media, asthma, type 1 diabetes, type 2 diabetes, atopic dermatitis, and hospitalization secondary to lower respiratory tract diseases (all infant outcomes).\u00a0We performed a Pubmed search or similar studies that were published after the AHRQ and included their data in the analysis.\u00a0Data Extraction: From the studies found we identified odds ratios or risk ratios and their corresponding confidence intervals.\u00a0We then converted these values and calculated the associated significance (p-values) of each.<span>\u00a0\u00a0 <\/span>Results:\u00a0Data collected from this secondary analysis reflects the risk associated with formula-use and the six aforementioned infant health outcomes.\u00a0Significant associations were found in all of the studies on otitis media, half of the studies on type 1 diabetes, and half of the studies on type 2 diabetes.\u00a0For the remaining conditions, the majority of associations were found to be insignificant.\u00a0\u00a0\u00a0 Conclusions:\u00a0Providing the data in this format, we construct formula-use as the deviant behavior we can adjust the language and attitudes surrounding exclusive breastfeeding and impact the way researchers approach and care-takers relay study results.<span>\u00a0\u00a0\u00a0 <\/span><\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Perceptions and Attitudes Toward the New Health Care Reform\u2014&#8221;Universal Coverage&#8221;\u2014Among Health care Providers in Thailand<\/span><\/p>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Patcharica Meteesatien and Sohini Sengupta<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Perceptions and Attitudes Toward the New Health Care Reform\u2014\u00a0\u201cUniversal Coverage \u201d\u2014Among Health care Providers in Thailand<span>\u00a0\u00a0\u00a0 <\/span>Patcharica Meteesatien and Sohini Sengupta\u00a0\u00a0\u00a0 ABSTRACT<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Background: Thailand implements universal health coverage policy to their new health care reform in 2001. Under the plan, patients pay 30 Baht per each visit until 2006 when the co-pay was revoked and medical service is now free of charge.\u00a0\u00a0 Aims: The goal of this study is to qualitatively explore (a) Thai physicains\u2019 knowledge and perceptions about the current policy, and (b) physicians\u2019 satisfaction with their practices after the implementation of the policy.\u00a0Methods: Qualitative in-depth in-person interviews of 17 physicians from three provinces (Lampang, Buri Rum, and Bangkok) of Thialand and observation. Notes are taken during the one hour interview.\u00a0\u00a0 Results and Discussion: Most of physicians interviewed express good understanding of the new health care reform and are able to incorporate the reform into their practices and make appropriate advices to patients regarding the policy and their rights. Physicians\u2019 satisfaction in practice shows strong correlation to their personal attitude toward the program. Fifteen out of seventeen physicians express some sort of dissatisfactions with the reform. Sources of dissatisfaction include: 1) increase risk of patients filing complaints against physicians and the hospital causing physicians to lack motivation and wary of increase responsibility. 2) Physicians\u2019 concern with patients\u2019 complaints to a lesser extend lead to increase in referral rates and a decrease in-patient service in the primary hospital. 3) Patients\u2019 abuse of their privilege, particularly free medications that is a part of the universal coverage program. 4) Moral hazard that association with decrease self care and promotion of health. 5) Lack of a formal referral system and referral centers. To improve the quality of care and increase physicians\u2019 satisfaction under the universal coverage, the issues stated above must be addressed.\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Acute and Persistent Pain after Breast Surgery<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Haley Meyer, Dr. Karamarie Fecho, Dr. Silvia Wilson<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Acute pain after breast surgery is a relatively common problem.\u00a0For most patients, postoperative pain is limited to the first few days after surgery.\u00a0However, persistent postoperative pain after breast surgery is a problem that was not recognized until recently, and it is unclear how many patients suffer from persistent postoperative pain and how best to treat such pain.\u00a0The present study determined the incidence of, and identified risk factors for, acute and persistent pain after breast surgery.\u00a0Data sources were medical records of females undergoing partial mastectomy (n equals 79), complete mastectomy (n equals 92) or complete mastectomy with immediate reconstruction (n equals 71).\u00a0Outcome variables were pain scores (0-10 VAS scale) measured in the post-anesthesia care unit (PACU) and 1-30 days and 6-12 months postoperatively.\u00a0Evaluated risk factors were preoperative and PACU pain, age, race, insurance, prior radiation or chemotherapy, obesity, and hypertension.\u00a0Preoperative pain scores averaged 0.79 plus or minus 0.17.\u00a0PACU pain scores averaged 4.95 plus or minus 0.22, with 61% of patients experiencing severe pain (VAS>5).\u00a0PACU pain increased with surgical complexity (p<0.0005).\u00a0Pain scores within the first postoperative month averaged 2.22 plus or minue 0.29, with 22% of patients experiencing severe pain.\u00a0Pain scores measured 6-12 months postoperatively averaged 0.75 plus or minus 0.20, with 8% of patients experiencing severe pain and 5% of patients reporting severe pain that arose after surgery.\u00a0Severe preoperative and PACU pain, younger age and non-white race were identified as risk factors.\u00a0Systolic hypertension was a protective factor.\u00a0These findings indicate that acute pain is problematic for the majority of breast surgery patients, while persistent pain is problematic for a small subset. <\/span><\/p>\n<\/div>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Impact of Oxacillin-resistant Staphylococcus aureus in Cystic Fibrosis<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Meredith E. Miller, Dr. Marianne Muhlebach, Dr. Jennifer Goodrich<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background:\u00a0Infection with ORSA is an increasing problem in the healthcare system and has important implications for CF patients. Studies on the impact of ORSA on CF disease progression show conflicting results.\u00a0It remains unclear how infection with CA versus HA strains affects the outcome and whether a universal eradication protocol is warranted.\u00a0\u00a0\u00a0\u00a0\u00a0 Aims:<span>\u00a0\u00a0 <\/span>The aim of this study is to determine the prevalence of CA and HA-ORSA at UNC\u2019s CF center and to assess the clinical impact of ORSA vs. OSSA on CF patients.\u00a0\u00a0\u00a0 Methods:\u00a0ORSA isolates were prospectively collected from respiratory cultures of CF patients for an 18 month period.\u00a0A cohort of CF patients colonized with OSSA was selected based on age, sex, and Pseudomonas aeruginosa status.\u00a0A retrospective review of clinical charts was then conducted to create a database of clinically relevant parameters associated with CF disease severity.<span>\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>Results:\u00a0Eighty-two each of ORSA and OSSA patients were included in the final analysis.\u00a0There was a significant difference (P < 0.001) in age at first S. aureus infection (13.3 yrs. for ORSA vs. 7.8 for OSSA).\u00a0There was no significant difference in FEV1% values before S. aureus infection but at 6 and 12 months post-infection, the mean FEV1% for ORSA patients was significantly lower (P < 0.05).\u00a0ORSA patients also had significantly more pulmonary exacerbations requiring IV antibiotics in 2006 (1.0 vs. 0.6).\u00a0Of the ORSA patients, 68 (83%) had HA and 14 (17%) had CA-ORSA; analysis of this aspect is ongoing.\u00a0\u00a0\u00a0\u00a0\u00a0 Discussion:\u00a0Analysis of local CF patients infected with ORSA vs. OSSA indicates a greater decline in FEV1 % during the year following infection but no significant long-term effect on pulmonary function.\u00a0A multicenter study would be more effective for assessing the impact of ORSA, and CA vs. HA strains, on CF patients.\u00a0\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Continental Variations in Pre-operative and Post-operative Management of Patients with Anterior Cruciate Ligament Lesions<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Lam Nguyen BS, Chad Cook PT, PhD, MBA, Eric Hegedus PT, DPT, MHSc, Allyson Sandago ATC, Ricardo Pietrobon MD, PhD, MBA, Claude T Moorman III, MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Surgeon decision making for non-operative anterior cruciate ligament (ACL) treatment and post-operative rehabilitation is influenced by a myriad of factors. The purpose of this study was to investigate inter-continental differences in surgeon decision making for care of the ACL deficient patient.\u00a0\u00a0\u00a0\u00a0 Materials and Methods: A survey which met the CHERRIES guidelines was administered to surgeons in 15 countries. Questions related to non-operative care management and post-operative\/rehabilitative management were provided to each respondent. Statistical analyses included multivariate comparisons among continents and regression findings for likelihood of targeting longer term non-operative treatment.\u00a0\u00a0\u00a0\u00a0 Results: Over six hundred (634) surgeons completed the survey, representing six continents. Continental variations were found in non-operative surgical decision making and post-operative\/rehabilitative management. Activity level and age greater than 10 years was associated with the likelihood of longer non-operative bouts of care.\u00a0\u00a0\u00a0\u00a0 Conclusion: Variations do exist across continents in the non-operative and post-operative\/rehabilitative management of patients with an ACL tear. Continental variations and disparate emphases such as activity level, age during injury, and bracing influenced treatment decision making<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Preliminary study of the impact of the daily dosage of antiretroviral therapy on adherence among people living with HIV\/AIDS<\/span><\/p>\n<div>\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Musheni Nsa<\/span><\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Although the use of combination antiretroviral therapy (ART) in HIV management reveals to be effective and to dramatically decrease the morbidity and mortality, treatment failure can result from nonadherence. This study was designed in order to determine how adherence is affected by dosage.\u00a0<strong>Methods:<\/strong> Two hundred and one patients were followed during one year at the UNC Infectious Diseases Clinic and the Wake County HIV Clinic for the SafeTalk study. Participants were interviewed at baseline, 4, 8, and 12 month follow-up sessions. Adherence level was assessed by pill count and the questionnaires. Data is expressed as mean percent of adherence and it was determined by using SAS program (Cary, NC).\u00a0<strong>Results: <\/strong>The mean adherence was decreased by the dosage 93.59%, n=944 observations, vs. 89.70%, n=460, one- and two-doses respectively. The adherence was not affected by the number of pills per dosage ranging from 1 to 5 pills.\u00a0<strong>Discussion &#038; Conclusion: <\/strong>In this study we found that a single daily dose of pills was much easier to follow by the patients than multiple dosages. Furthermore, the number of pills per dosage seemed not to have affected the adherence. Taken together, these observations suggest that adherence to ART is affected by dosage per day rather than the number of pills per dosage.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Use of Color-Coded BMI Charts Improves Parent Understanding of BMI<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Joanne Finkle, RN, JD, Steven Pattishall, Lisa Whitehead, MD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Many parents underestimate their children\u2019s weight status and many not make appropriate nutrition and physical activity changes as a result. While body mass index (BMI) is an effective and efficient obesity screening tool, pediatric health care providers underuse BMI, and little information exists about whether parents understand the concept of BMI\u00a0\u00a0\u00a0 Aims: This study aims to determine how well parents of young children (ages 3-8) understand BMI using both standardized and augmented (color-coded) BMI charts.\u00a0Furthermore, it seeks to determine the relationship between literacy and numeracy skills and the ability to correctly comprehend BMI.\u00a0\u00a0\u00a0\u00a0\u00a0 Methods: Fifty parents were interviewed at the UNC Pediatric Continuity Clinic using a demographics survey, a math skills test (WRAT), a literacy test (STOFHLA), and the \u201cUnderstanding BMI\u201d survey, a survey we devised to determine parents\u2019 understanding of both standard and color-coded BMI charting. Analysis with STATA 10.0 determined the relationships between demographic variables and BMI understanding, as well as correlations between the WRAT, the STOFHLA, and the Understanding BMI survey results.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Results: Race, number of children, education, insurance, WIC enrollment, primary language, and income all were related to understanding of BMI. Positive correlations were found between scores on both the WRAT and STOFHLA and the Understanding BMI survey (r equals 0.58, p less than 0.0001, and r equals 0.59, p less than 0.0001, respectively).\u00a0Those of lower (as opposed to higher) literacy and numeracy were more likely to increase their understanding with augmented, color-coded BMI charts.\u00a0\u00a0\u00a0\u00a0 Discussion: Individuals with higher literacy or numeracy had greater understanding of both standard and augmented BMI charts. Color-coded BMI charts will likely improve overall understanding of children\u2019s BMI by their caregivers, particularly those with lower math and literacy skills.\u00a0Further research is needed to determine if improved understanding of their children\u2019s BMI leads to greater parental motivation to adopt healthy lifestyle changes and improved childhood weight trajectories.\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Functional Analysis of Secreted frizzled related protein 2 (Sfrp2) in Mouse Endothelial Cells<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Demore, Nancy M.D. Olsson, Erik Ketelsen, David<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background Secreted frizzled related protein 2 (Sfrp2) has been investigated for its role as a paracrine factor mediating myocardial cell survival and repair (1). The gene has also been identified as overexpressed in breast cancer tumor endothelial cells and confirmed at the phenotypic level using IHC (2). Sfrps have been implicated in a variety of cellular processes including cell proliferation and cell death (3).\u00a0Methods 24 and 48 hour proliferation assays were performed in the presence and absence of serum and Sfrp2. After incubation in experimental conditions, cells were counted using a hemocytometer and compared to controls with and without serum. For the migration assay cells were serum-starved overnight and added to a 12-well migration plate with experimental conditions in the base and allowed to migrate for 6 hours before staining. Apoptosis was determined using the Caspase 3 Assay Kit (Sigma) after treatment with Sfrp2 for 24 hr under hypoxic conditions.\u00a0Results After addition of 10 uL rmSfrp2 (R&#038;D Systems Minneapolis, MN) and incubation at 37C for 24 hours the median cell count for the control group was 2.25&#215;10^4 (95% confidence interval 2.22 to 2.28). The median cell count for the wells treated with Sfrp2 was 4.0&#215;10^4 (95% CI 3.98 to 4.02). A T-test was performed on the data and the value was calculated to be 5.2&#215;10^-6. We were unable to achieve these results in repeat experiments under the same conditions. Unfortunately Analysis of Migration assays was unsuccessful due to undetermined reasons.\u00a0\u00a0 Discussion Our data suggest that secreted frizzled related protein 2 (Sfrp2) is not involved in promoting the proliferation of MECs in vitro. Further investigation is warranted to determine the role of Sfrp2 in migration and apoptosis. Our lab plans to perform knockdown experiments with siRNA against Sfrp2 to provide further evidence for Sfrp2\u2019s involvement in MEC proliferation<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Shifting from mitigation to prevention using Geographic Information Systems to identify and reach vulnerable populations<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Andy Hull, Jeff Davis, Dohyeong Kim, Marie Lynn Miranda<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Geographic Information Systems (GIS), a tool for managing, visualizing, querying, and analyzing information linked to geographic locations, have been used to analyze environmental exposures and their relationships to health outcomes.\u00a0Our environments are important determinants of health status and outcomes.\u00a0Science and medicine are growing to understand that even the expression of our genes is heavily influenced by our environments.\u00a0A tool to map populations within their environments can be used to better understand the interaction between vulnerable populations, their environments, and their health outcomes.\u00a0We have developed a tool to help prevent childhood lead poisoning and exposure before it begins by linking several datasets within a GIS.\u00a0Collaborating with the North Carolina Children\u2019s Environmental Health Branch and health care providers, the Children\u2019s Environmental Health Initiative has designed a GIS based tool to identify children as risk of lead exposure to try to move from mitigation to prevention.\u00a0We combined tax assessor housing information at the tax parcel level, childhood blood lead level testing results, and census data to produce county wide lead exposure risk models at the individual tax parcel level.\u00a0These models are used to identify children living in homes where they might be exposed to bioavailable lead.\u00a0Once identified, efforts are made to screen older children as a method of secondary prevention.\u00a0Primary prevention is done by educating parents of infants before they are exposed about lead exposure risks and exposure prevention strategies.\u00a0This tool is now being converted to a web-based application that can be used by parents and providers to better understand the potential for exposure.\u00a0GIS holds great potential for applications to other heath outcomes and can be used to explore and analyze the relationship between health outcomes and the social and physical environment.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Shifting from mitigation to prevention using Geographic Information Systems to identify and reach vulnerable populations<\/span><\/p>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Andy Hull, Jeff Davis, Dohyeong Kim, Marie Lynn Miranda<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Geographic Information Systems (GIS), a tool for managing, visualizing, querying, and analyzing information linked to geographic locations, have been used to analyze environmental exposures and their relationships to health outcomes.\u00a0Our environments are important determinants of health status and outcomes.\u00a0Science and medicine are growing to understand that even the expression of our genes is heavily influenced by our environments.\u00a0A tool to map populations within their environments can be used to better understand the interaction between vulnerable populations, their environments, and their health outcomes.\u00a0We have developed a tool to help prevent childhood lead poisoning and exposure before it begins by linking several datasets within a GIS.\u00a0Collaborating with the North Carolina Children\u2019s Environmental Health Branch and health care providers, the Children\u2019s Environmental Health Initiative has designed a GIS based tool to identify children as risk of lead exposure to try to move from mitigation to prevention.\u00a0We combined tax assessor housing information at the tax parcel level, childhood blood lead level testing results, and census data to produce county wide lead exposure risk models at the individual tax parcel level.\u00a0These models are used to identify children living in homes where they might be exposed to bioavailable lead.\u00a0Once identified, efforts are made to screen older children as a method of secondary prevention.\u00a0Primary prevention is done by educating parents of infants before they are exposed about lead exposure risks and exposure prevention strategies.\u00a0This tool is now being converted to a web-based application that can be used by parents and providers to better understand the potential for exposure.\u00a0GIS holds great potential for applications to other heath outcomes and can be used to explore and analyze the relationship between health outcomes and the social and physical environment.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Pharmacological Observation of the Acute Reciprocal Relationship of Vagal Tone and Sympathetic Nerve Activity<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">(1) Palvia, Tanuj P.\u00a0(2) Taylor, J. Andrew, Ph.D.<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">PURPOSE: In the human body, there are indications that the sympathetic and parasympathetic systems share a reciprocal relationship. We wish to identify that an acute reciprocal relationship exists and if this relationship can be maintained via continuous exercise training through the aging process. We observe if pharmacologically decreasing vagal tone can incur an acute increase in the resting level of sympathetic activity in young sedentary individuals and master\u2019s athletes.<span>\u00a0\u00a0 <\/span>METHODS: ECG, arterial pressure, and mean sympathetic nerve activity (obtained via microneurogrpahy in the peroneal nerve) were recorded before and after administering vagolytic doses of atropine on 8 young sedentary and 7 master\u2019s athletes. All waveforms were stored to computer for subsequent processing and analysis.<span>\u00a0\u00a0\u00a0 <\/span>RESULTS\/STATISTICS: In young sedentary individuals, mean heart rate increased from 64.67 to 70.02 beats\/min (p=0.14), mean systolic BP increased from 111.7 to 117.39 mmHg (p = 0.053), mean diastolic BP increased from 60.43 to 62.63 mmHg (p=0.23). Mean MSNA decreased 40.68% from 17.66 to 10.47 bursts\/heart rate (p=0.1369).\u00a0In master\u2019s athletes, mean heart rate increased from 52.35 to 64.22 beats\/min (p=0.007), mean systolic BP increased from 117 to 123.32 mmHg (p=0.12), and mean diastolic BP increased from 72.47 to 78.52 mmHg (0.015). Mean MSNA decreased 21.28% from 61.7 to 48.5675 bursts\/heart rate (p=0.5879). CONCLUSIONS: This study demonstrates that pharmacologically decreasing vagal tone does not acutely increase the resting level of sympathetic activity in young sedentary populations. Also, this relationship cannot be identified in master\u2019s athletes, thus preventing us from identifying preserved reciprocal relationship of the autonomic limbs via continuous exercise training through the aging process. Limitations of the study include confounding by the baroreceptor reflex, small sample size, and noise in sympathetic nerve activity measurement.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">The Effect of Literacy and Numeracy on How Parents Understand Instructions for Medical Care of Their New Baby<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Steven Pattishall, Matthew Oettinger, Joanne Finkle, RN, JD, Russell Rothman, MD, MPP and Eliana Perrin, MD, MPH<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Purpose: New parents receive many health-related recommendations and instructions from a variety of sources concerning the care of their baby, but this information may not always be correctly understood leading to potentially serious health outcomes. We sought to examine the connection between parents\u2019 general literacy and numeracy skills and their ability to interpret basic, common instructions regarding the care of their babies.\u00a0Methods: Parents or caregivers of children less than 1 year of age were approached during a visit to the pediatric continuity clinic at UNC Hospitals and asked to participate in the study.\u00a0They completed demographic information, a standardized literacy test (STOFHLA), numeracy test (WRAT-3), and answered questions related to various common pediatric health-related activities. The health-related questions were part of the 20 question Pediatric Health Activities Test (PHAT), which included questions regarding interpretation of thermometer read-outs, directions for formula preparation, and dosing of medications, among others. Completing the entire study took approximately 45 minutes and the parents were reimbursed for their time. The data were analyzed to determine correlations between both STOFHLA and WRAT scores with PHAT scores using the statistical program STATA (version 10.0).\u00a0Results: Fifty-two caregivers were recruited and successfully completed all parts of the study.\u00a0The average age of the parents was 26, with an average of 13.3 years of education. We found the STOFHLA literacy test results to be correlated with the PHAT scores (r0.35, p0.01). We also discovered an even stronger correlation between an individual\u2019s WRAT numeracy scores and their PHAT scores (r0.47, p0.001).\u00a0Conclusion: Parents literacy and numeracy skills both appear to be correlated to their ability to successfully interpret information regarding health-related information concerning their infant. When providing instructions or anticipatory guidance to parents of infants, pediatric providers should be aware of their potential limitations in literacy and numeracy.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Interrogating the Serine Hydrolase Proteome of Human Platelets with Carbamate Probes<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Ryan Phillips, Stephen P. Holly, Zhengyan Wang, Weiwei Li, Ben Cravatt, Leslie V. Parise<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">CONTEXT:\u00a0The American Heart Association estimates that coronary heart disease and stroke will account for approximately 600,000 deaths in the US this year.\u00a0Platelet aggregation is a key factor in the formation of thromboemboli that occlude blood vessels and lead to these conditions.\u00a0\u00a0\u00a0 OBJECTIVES:\u00a0To screen a library of carbamate moiety containing small molecules for human platelet activity modulation in order to identify potential drug candidates and novel platelet signaling pathways.\u00a0\u00a0\u00a0 METHODS:\u00a0Washed human platelets were incubated in each of 120 library compounds, activated with thrombin receptor-activating peptide (TRAP) and then subjected to flow cytometry to measure fibrinogen binding and P-selectin exposure.\u00a0The effect of selected library compounds on platelet aggregation was then probed through aggregometry.\u00a0The toxicity, with respect to human platelets, of these compounds was determined using an LDH assay.\u00a0\u00a0\u00a0 RESULTS: Flow cytometry analysis led to identification of 13 library compounds that decreased platelet fibrinogen binding and P-selectin exposure by greater than 50%.\u00a0Aggregometry confirmed that platelets treated with these compounds showed decreased aggregation when activated with TRAP.\u00a0LDH assays of platelets treated with these compounds suggest little or no lysis or permeablization.\u00a0\u00a0\u00a0 DISCUSSION:\u00a0The most potent library compound demonstrated the ability to decrease platelet aggregation to just 6.25% of maximum.\u00a0Further testing is in order to confirm these results, as well as to probe the broader toxicities of this and other compounds of promise.\u00a0In addition, investigation into the possible targets of these compounds is ongoing and will potentially elucidate novel signaling molecules and pathways.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Quantitative Assessment of the p53-Mdm2 feedback loop using protein lysate microarrys<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Sundhar Ramalingam1, Peter Honkanen2, Lynn Young3, Tsutomu Shimura4, John Austin2, Patricia S. Steeg1,4 and Satoshi Nishizuka1,5<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Mathematical simulations of the p53\u2013Mdm2 feedback loop suggest that both proteins will exhibit impulsive expression characteristics in response to high cellular stress levels. However, little quantitative experimental evaluation has been performed, particularly of the phosphorylated forms.\u00a0To evaluate the mathematical models experimentally, we used lysate microarrays from an isogenic pair of gamma ray\u2013irradiated cell lysates from HCT116 (p53 \/\u00a0and p53-\/-). Both p53 and Mdm2 proteins showed expected pulses in the wild type, whereas no pulses were seen in the knockout. Based on experimental observations, we determined model parameters and generated an in silico &#8216;knockout&#8217;, reflecting the experimental data, including phosphorylated proteins.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Volumetric Analysis of Brain Metastases Following Stereotactic Radiosurgery<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Suzanne Rhodes<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><em><span style=\"font-size: 10pt;\">Background:<\/span><\/em><span style=\"font-size: 10pt; color: black;\">\u00a0Stereotactic radiosurgery is frequently offered to patients with brain metastases as a minimally invasive treatment option.\u00a0Following stereotactic radiosurgery, the volume of metastatic lesions measured with magnetic resonance imaging may not change until months after treatment.\u00a0However, in other patients, the volume of treated lesions may appear to decrease or even increase during the weeks following treatment.\u00a0We have performed an analysis of volume changes of metastatic brain lesions following radiosurgery treatment.\u00a0<\/span><em><span style=\"font-size: 10pt;\">Methods:\u00a0<\/span><\/em><span style=\"font-size: 10pt;\">Sixty adult patients having undergone Gamma Knife stereotactic radiosurgery (SRS) for metastatic brain disease between August 2001 and March 2007 at the University of North Carolina, Chapel Hill were enrolled in a retrospective study. Thirty-six patients (60%) had a single lesion, and twenty-four (40%) had multiple lesions (range 2-5) at initial treatment.\u00a0\u00a0 Ninety-six metastatic lesions were analyzed for lesion volume using RECIST criteria (uni-dimensional), WHO criteria (bi-dimensional), and manual image segmentation software (3-dimensional).\u00a0Measurements of tumor volume were taken at baseline and available follow-up dates.\u00a0<em>Results:<\/em>\u00a0Thirty-four lesions (35%) increased in volume \u2265 20% when compared to baseline at any follow-up time point, whereas sixty-two lesions (65%) never increased in volume \u2265 20% from baseline on follow-up MRIs.\u00a0Twenty-four patients (40%) had at least one treated metastasis to increase in volume \u2265 20% from baseline on follow-up MRI, whereas thirty-six patients (60%) never had a lesion to increase in volume \u2265 20% from baseline on follow-up.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Parathyroidectomy for Renal Hyperparathyroidism at UNC: A Retrospective Review<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Christina Russell<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Chronic kidney disease (CKD) requiring hemodialysis is common in the United States and currently affects about 100,000 Americans. End-stage renal failure often results in hyperparathyroidism as a result of calcium ion homeostasis imbalance. In 2004 cinacalcet HCl (Sensipar) was introduced to treat renal hyperparathyroidism by lowering the threshold at which parathyroid chief cells detect calcium ions. Still, even with this innovation in medicine, parathyroidectomy is sometimes necessary for renal hyperparathyroidism that does not respond to treatment. This study is a retrospective chart review of patients who have undergone parathyroidectomy for renal hyperparathyroidism at UNC Chapel Hill hospitals from 1997 to 2007. Patients who were taking cinacalcet immediately before their parathyroidectomy were found to have a significantly higher chance of developing hypocalcemia during their post-operative course, 61.5% compared to 40.6% of the control group.\u00a0Hypocalcemia was defined in this study as requiring IV calcium supplementation. Cinacalcet\u2019s mechanism of action lowers serum calcium; however more research is needed to determine if the drug is causing this hypocalcemia phenomenon directly or by selecting out the sickest patients for surgery. <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span>Identification of new foci of artesunate-mefloquine resistant Plasmodium falciparum in Cambodia using molecular surveillance<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Shah NK, Alker AP, Sem R, Ariey F, Duong S, Wongsrichanalai C, Rogers W, Meshnick SR<\/span><\/p>\n<div>\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Emergence of multi-drug resistant <em>\/Plasmodium falciparum\/<\/em> malaria along the Thai-Cambodia border led to the introduction of artesunate-mefloquine combination therapy in 2000. Reports of increasing treatment failures of artesunate-mefloquine and geographic variations in resistance suggest the need for expanded surveillance in Cambodia. Increased \/pfmdr1\/ gene copy numbers predict \/in vivo \/treatment failure to mefloquine alone as well as to artesunate-mefloquine. We evaluated the feasibility of a national molecular surveillance program for artesunate-mefloquine resistance by assessing \/pfmdr1\/ mutations. Clinical isolates of <em>\/P.falciparum\/<\/em> were collected from sites in Western Cambodia (Pailin, Kampong Seila), Central Cambodia (Chumkiri), and Eastern Cambodia (Memut and Rattanakiri). Samples were genotyped for \/pfmdr1\/ copy number and codons 86, 184, 1034, and 1042 using real-time PCR. We assessed the relationship between clinical characteristics and \/pfmdr1\/ mutations with parametric and non-parametric analyses. From 2004-2006, 768 isolates were collected and 730 (95.1 %) were successfully genotyped of which 197 (26.9 %) possessed multiple copies of \/pfmdr1\/. Median copy number varied by site: Pailin (1.34, n=177), Kg. Seila (1.53, n=10), Chumkiri (2.11, n=112), Memut (1.07, n=165), and Rattanakiri (1.05, n=287). The proportion of isolates with multiple copies of \/pfmdr1\/ was also greater in the west and center of the country compared to the eastern regions (54.0% versus 6.1%, OR = 8.72, 95%CI: 6.73, 10.72). \/pfmdr1\/ SNPs were largely wild-type and did not vary by site with the exception of 184-Phe whose prevalence was higher in the West and Central regions (Chi-square = 341.7, p<0.001). In multivariate analysis site and parasite burden remained associated with \/pfmdr1\/ amplification (p<0.001).\/\/ The results reveal a high prevalence of geographically clustered artesunate-mefloquine resistance in Cambodia which cannot be explained by variations in clinical or demographic characteristics. Artesunate-mefloquine resistance was believed to be restricted to areas along the Thai border and its presence in Central Cambodia is alarming. Malaria control programs in endemic settings can conduct molecular surveillance and detect previously unknown foci of antimalarial resistance prior to reports of clinical failure.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">The Role of iNOS in Hepatic Progenitor Cell Proliferation and Differentiation<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Yiqing Sheng, David Gerber, Natasha Wright<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">The regenerative capacity of the liver has attracted the interest of many who continue to explore the cellular pathways within the hepatic microenvironment. They do so in hope of developing alternative therapies that may avoid the limitations in whole-organ transplant in treating end-stage liver disease. The Gerber lab at UNC-CH has isolated from the adult liver a somatic-derived hepatic progenitor cell (HPC) population that demonstrate bipotent capability to differentiate towards hepatocytic and biliary phenotypes. After partial hepatectomy, increased expression of a cytokine tumor necrosis factor (TNF)-alpha has been shown to indirectly increase the production of Interleukin-6 (IL-6). Together, TNF-alpha and IL-6 upregulate inducible Nitric Oxide Synthase (iNOS), which converts L-arginine to nitric oxide. iNOS seems to be involved in both proliferative and apoptotic processes in the mature hepatocyte. Recent studies have shown that TNF-alpha supplementation alone or in combination with IL-1B in cultures can induce iNOS expression within HPC\u2019s, which subsequently expressed hepatic and biliary genes as shown by PCR analysis. Further investigation after incubation of HPC\u2019s with TNF-alpha alone and in combination with IL-1B using Western Blot and MTT assay are needed to confirm their capabilities in differentiation and proliferation. In this study, preliminary Western Blot data showed that Sca-1\u00a0HPC\u2019s consistently expressed albumin markers on day 0 and 20 hours after addition of cytokines. CK-19 markers were never observed. MTT assay indicated a drop in cell count at 20 hours after the addition of cytokines followed by a rise in cell numbers until day 7 in Sca-1\u00a0HPC\u2019s incubated with both TNF-alpha\u00a0and IL-1B and with TNF-alpha alone. However, proliferation was more apparent under the influence of TNF-alpha alone than with both TNF-alpha and IL-1B. Due to time constraints, the preliminary data is inconclusive. Repeats of the same work needs to be done for reproducibility and confirmation of current results.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Vascular Tissue and Thrombin Generation<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Samar<\/span><span style=\"font-size: 10pt;\"> Sheth, Alok Pathak, Rick Stoffer MD<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Despite treatment with antiplatelet agents, thrombotic events occur in patients. Thus questioning the role of platelets in the clotting cascade and acute thrombosis. Previous data from this lab has shown that in the presence of healthy tissue (freshly harvested internal mammary artery) and in cell culture (human aortic smooth muscle cells (HASMC)) it is possible to generate significant amounts of thrombin in the absence of platelets.\u00a0\u00a0\u00a0\u00a0 Methods: HASMCs, cultured in 24 well plates using a DMEM:SMBM media mix, were grown to 80% confluence. They were then incubated with reptilase treated, ultracentrifuged- platelet poor plasma (PPP) for 1.5 hours, or incubated with specific factor deficient platelet poor plasmas (FIX, FVIII, FVII, etc) using the same preparation as normal PPP. Tissue factor and CaCl2 were then added at final concentrations of 0.6pM and .5mM respectively. At 5 min intervals for 120min, 15microliters of plasma was added to 3.8% sodium citrate in a 96 well plates.\u00a0S-2238 was added and optical density was measured at 405 lamba and thrombin generation was quantified.\u00a0\u00a0\u00a0\u00a0 Results\/Conclusions: Preliminary data using HASMCs has shown that PPP thrombin generation reaches a peak at approximately 20 mins. FVIII deficient PPP reaches a peak as well, but the peak is delayed, and doesn\u2019t appear to reach the level of normal PPP. Interestingly data suggests FIX deficient PPP also reaches a peak similar to the peak of normal PPP, however at a delayed time point. These data suggest that the intrinsic pathway is necessary for the propagation of thrombin and speed at which thrombin generated. These findings are supported by various other models of thrombin generation. We hope to further elucidate the roles of the intrinsic and extrinsic pathways in thrombin generation in cultured HASMCs, as well as understand pathways responsible for thrombin generation in these platelet poor systems.\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Prenatal Mild Ventriculomegaly Predicts Abnormal Development of the Neonatal Brain<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">John H. Gilmore, MD; Lauren Smith, Honor Wolfe, MD; Barbara Hertzberg, MD; J. Keith Smith, MD; Nancy Chescheir, MD; Dianne Evans, MA, Chaeryon Kang; Robert M. Hamer, Weili Lin, PhD, Guido Gerig, PhD<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Although mild ventriculomegaly (MVM) is one of the most common fetal brain abnormalities, little is known the effects it has on neurodevelopment after birth.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Aims: The main aim of this study is to determine if children with prenatal isolated MVM have alterations in brain development after birth.\u00a0\u00a0\u00a0\u00a0 Methods: Patients were recruited to the study from UNC Hospitals and Duke University Medical Center after a diagnosis of MVM on routine ultrasound.\u00a0Using magnetic resonance imaging (MRI) in the first weeks after birth, we assessed gray and white matter development with automated tissue segmentation and quantitative tractography of diffusion tensor images (DTI) in 34 children with MVM and 34 age and gender-matched controls.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Results: Neonates with prenatal MVM had significantly larger lateral ventricle volumes (286.4 percent; p less than 0.0001), intracranial volumes (7.1 percent, p equals 0.0063), and cortical gray matter volumes (10.9 percent, p equals 0.0004) than matched controls. MVM cases have overall larger gray matter volumes (p equals 0.0010) and smaller white matter volumes (p equals 0.0125) than controls when normalizing for intracranial volume. DTI tractography revealed a significant increase of mean diffusivity in most white matter tract regions, while fractional anisotropy was significantly decreased in several white matter tract regions.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Conclusions: Prenatal enlargement of the lateral ventricle is associated with significant enlargement of the lateral ventricles after birth, as well as increased gray matter volumes, reduced white matter volumes, and delayed or abnormal maturation of DTI properties in the corpus callosum and cortico-spinal tracts.\u00a0This study suggests that prenatal ventricle volume may be an early structural marker of dysmaturation of the cerebral cortex after birth and a risk for neuropsychiatric disorders, such as schizophrenia, that are associated with ventricle enlargement.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">DYSREGULATION OF MICRORNA IN THE PREFRONTAL CORTEX OF BIPOLAR PATIENTS<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Benjamin N Stepp, Clark D Jeffries, Joel S Parker, Diana O Perkins<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">MicroRNA (miRNA) expression has become an area of intense research due to the critical role they have been found to have in post-transcriptional regulation.\u00a0These regulatory mechanisms have been found to be dysfunctional in bipolar disorder and schizophrenia, specifically regarding neurodevelopment and synaptic plasticity, respectively.\u00a0We investigated the miRNA expression profile in the prefrontal cortex (PFC) of subjects with bipolar disorder compared to that of pyschiatrically unaffected and schizophrenic subjects.\u00a0PFC from 14 subjects with bipolar disorder, 15 with schizophrenia, and 21 unaffected were case matched for post-mortem interval (PMI), age, gender, and hemisphere.\u00a0Oligonucleotide probes were synthesized in duplicate for 264 human miRNAs antisense to the mature sequence reported in the Sanger miRNA registry and hybridization was performed.\u00a0Assuming a FDR of 5%, 16 miRNAs were differentiated in PFC of bipolar compared with unaffected subjects.\u00a0Trends of these comparisons were mirrored in bipolar versus schizophrenia. We also compared 12 miRNAs previously shown to be differentially expressed in schizophrenia with bipolar subjects and found a pattern similar to that of schizophrenia versus unaffected, with the same 12 miRNAs differentially expressed in a similar direction.\u00a0The results of this study show a set of miRNAs differentially expressed in the PFC of persons with bipolar disorder as compared to psychiatrically unaffected subjects and to subjects with schizophrenia.\u00a0In addition, the schizophrenia subjects similarly have a characteristic set of miRNAs differentially expressed when compared to psychiatrically unaffected and bipolar subjects.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Direct Comparison of Noninvasive Physiologic Measurements in a Multicenter Cohort of Emergency Department Patients Evaluated for Suspected Pulmonary Embolism<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Michael Steuerwald, Brian J. O&#8217;Neil, David C. Portelli, Michael C. Plewa and Jeffrey A. Kline<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Objectives: We tested which of 15 physiologic parameters discriminate PE\u00a0from PE\u2013.<span>\u00a0\u00a0\u00a0\u00a0 <\/span>Methods: 437 emergency department (ED) patients with suspected PE were prospectively enrolled at 7 U.S. hospitals. We first obtained room-air vital signs, arterial blood gases, pulse oximetry, and breath samples. All patients then had pulmonary vascular imaging and 90-day follow-up. PE was diagnosed (PE ) and excluded (PE\u2013) via rigorous peer-reviewed criteria.\u00a0\u00a0\u00a0 \u00a0Results: 97 (22%) patients were PE\u00a0and 340 (78%) were PE\u2013. We observed no significant difference in body mass or vital signs. PE\u00a0patients were older (56 \u00b1 18 years vs. 49 \u00b1 16 years), with lower oxygen saturation (SaO2) (94% \u00b1 6% vs. 96% \u00b1 4%) but not partial arterial oxygen tension (PaO2) (72 \u00b1 20 torr vs. 80 \u00b1 20 torr). Alveolar minute ventilation was increased (8.3 \u00b1 4.0 L vs. 6.5 \u00b1 2.8 L) with trend of increased tidal volume (565 \u00b1 288 mL vs. 503 \u00b1 263 mL) and with shortened exhalation time (1.8 \u00b1 0.8 sec vs. 2.1 \u00b1 0.9 sec). Alveolar dead space (VD\/VTalv) was increased (33% \u00b1 20% vs. 19% \u00b1 17%) with proportional decrease in mixed expired CO2 (PeCO2, 17 \u00b1 6 mm Hg vs. 22 \u00b1 5 mm Hg) and end-tidal CO2 (PetCO2, 29 \u00b1 7 mm Hg vs. 36 \u00b1 6 mm Hg). PeCO2 and PetCO2 had the highest areas under the ROC curve (AUCs) (0.71 and 0.74), with lower-limit 95% confidence intervals >0.6. No other parameter had an AUC >0.64.\u00a0\u00a0\u00a0\u00a0 Conclusions: In symptomatic ED patients, age, weight, vital signs, SaO2, and PaO2 poorly discriminated PE\u00a0from PE\u2013. PE markedly increased alveolar dead space, manifested as low exhaled CO2. Among 15 physiologic parameters, PeCO2 and PetCO2 had the highest, albeit marginal, discriminatory value.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">High Rates of Depression and Cardiovascular Risk Factors in Rural Mexico<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Lorene A. Temming, Kristoff A. Olson, Charles R. Clover, Sandra C. Clark, Mauricio G. Cohen<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background:<span>\u00a0\u00a0 <\/span>Cardiovascular disease (CVD) and depression are estimated to be the first and second largest contributors to the global burden of disease by 2020.\u00a0Depression is an independent risk factor for developing CVD.\u00a0There is a paucity of data regarding CVD risk and depression among rural Mexicans, a population likely to emigrate to the US.\u00a0We assessed the prevalence of CVD and depression among rural Mexicans.\u00a0\u00a0\u00a0 Methods:\u00a0\u00a0 Participants were recruited from 9 rural communities in Guanajuato, Mexico.\u00a0We screened for depression using the nine-question Patient Health Questionnaire (PHQ-9). Participants with scores of 10-14 were considered moderately depressed, and scores >15 were considered severely depressed. Participants were screened for elevated blood pressure, impaired glucose tolerance, hypercholesterolemia, waist-to-hip ratio, and for low HDL cholesterol.\u00a0\u00a0\u00a0 Results:\u00a0\u00a0 A total of 432 participants were screened and interviewed. Mean age was 45.8 years and 79.4% were female.\u00a0Prevalence of elevated blood pressure was 38.4% and 21.3% of participants had impaired glucose tolerance. Frequency of elevated total cholesterol and HDL cholesterol was 16.6% and 81.8%, respectively. Abdominal obesity rates were 82.2%. According to modified ATP III criteria, 49.8% of our sample had metabolic syndrome. Moderate or severe depression was present in 25.9% of subjects. Aside from age, depression showed no statistical correlation with CVD risk factors.\u00a0\u00a0\u00a0\u00a0 Conclusions:\u00a0\u00a0 We found a high prevalence of CVD risk factors and depression among rural Mexicans. However, there was no clear correlation between CVD risk factors and depression in our sample. Most noteworthy in our study were high rates of metabolic syndrome and low HDL in this relatively young cohort of mostly women. Further research is needed to gain insight into the reasons for the high prevalence of depression and CVD risk factors in the rural Mexican population. Strategies for early preventive therapies should be considered in this population.\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Three-Dimensional Images and Vessel Rendering Using Optical Coherence Tomography<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Meghan W Thomas, James M. Grichnik MD PhD (DUMC), and Jospeh A. Izatt PhD (Duke University)<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Purpose: To evaluate improvements in optical coherence tomography\u2019s handheld technology and software on dermatological applications.\u00a0\u00a0\u00a0\u00a0 Method: An institutional review board approved a small clinical trial at Duke\u2019s Dermatology clinic.\u00a0Patients coming to the clinic for previously scheduled appointments were asked to participate.\u00a0Once consented, their skin lesions were imaged with the OCT machine and photographed for comparison.\u00a0The system had a 1310 nm laser with a lateral resolution of 20 microns and a penetration depth of approximately 1.8 mm. Vessel rendering software was then used to trace imaged vascular lesions.\u00a0\u00a0\u00a0 Results: 3-dimensional images of hemangiomas, telangiectasias, and a psoriatic plaque were acquired.\u00a0Videos of the scans were recorded and telangiectatic vessels were rendered.<span>\u00a0\u00a0\u00a0 <\/span>Conclusion:\u00a0The use of OCT in the clinical setting is increasing especially with improvements in technology and software.\u00a0Optical coherence tomographic technology may play a significant role in future bedside dermatologic diagnostics.\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Integrin Associated Protein (IAP) Cleavage and Vascular Smooth Muscle Proliferation<\/span><\/p>\n<div>\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Diabetic patients with elevated blood glucose levels have a greatly increased risk of developing atherosclerosis due to increased vascular smooth muscle proliferation.\u00a0Vascular smooth muscle cells grown in high glucose (25 mM) are more responsive to IGF-1 than smooth muscle cells that are grown in physiologically normal concentrations of glucose (5 mM).\u00a0IGF-1 activates a signaling cascade in vascular smooth muscle cells that are grown in high glucose, and this signaling cascade results in altered gene transcription and increased smooth muscle cell growth.\u00a0In order for this signaling cascade to be activated, the extra-cellular domain of Integrin Associated Protein (IAP) must first associate with SHPS-1.\u00a0In physiologically normal 5mM glucose, IAP is known to be cleaved by MMP-2, which prevents activation of the signaling cascade and results in no increased smooth muscle cell proliferation.\u00a0In high glucose (25mM), IAP is not cleaved and is able to associate with SHPS-1.\u00a0The aim of this experiment was to determine the IAP cleavage site and to study the effect that protecting the IAP cleavage site from cleavage would have on smooth muscle cells grown in both high and low glucose.\u00a0Smooth muscle cells containing a mutated version of IAP were developed, and gel electrophoresis was used to determine that the mutation blocked the cleavage of IAP.\u00a0A cell growth assay was used to examine what effect blocking IAP cleavage would have on smooth muscle cells grown in low glucose.\u00a0Preliminary data suggests that protecting IAP from cleavage is not enough to trigger smooth muscle cell proliferation in low glucose, and it is hypothesized that other pathways must also be involved.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Surgical Treatment of Locally Recurrent and Locally Advanced Rectal Cancer with and without the Addition of Intraoperative Radiation Therapy<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Matthew Triplette, Michael Meyers, MD, Benjamin Calvo, MD<\/span><\/p>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Introduction: Intraoperative Radiation Therapy (IORT) has become increasingly utilized in a multimodal approach including surgical resection with curative intent of recurrent and locally advanced rectal cancer; however, many studies have been inconclusive as to its benefit on local control and recurrence rates.\u00a0\u00a0\u00a0\u00a0\u00a0 Objectives: It is important to establish whether IORT has consistent tangible benefits to patient disease-free survival as its use is associated with logistical hurdles and significant perioperative morbidities.\u00a0We hypothesize that the addition of IORT to a curative resection in the treatment of locally recurrent and locally advanced rectal cancer reduces further recurrence rates and improves survival in these patients without significantly affecting operative outcomes such as morbidity and hospital stay.\u00a0\u00a0\u00a0 Methods:\u00a0This is a single institution, retrospective review of all locally recurrent and locally advanced rectal cancer patients who underwent IORT in addition to curative surgical resection between the years of 2001-2006, and an adequate number patients to serve as a control, who underwent the same surgical procedure and adjuvant therapy without IORT in the proceeding years.\u00a0Complete data sets were collected on all patients including tumor staging and surgical margins, as well as operative variables.\u00a0Longitudinal information was also collected on all patients to determine post-operative status and further recurrence.\u00a0The data was then analyzed.\u00a0\u00a0\u00a0 Results:\u00a0After preliminary analysis, it appears that there is significant difference between overall survival and local recurrence rates in the two populations.\u00a0For patients with IORT, local recurrence rate and death rate was found to be 14.6% and 43.9% respectively, while these values were significantly higher at 23.7% and 60.5% in those patients without IORT.<span>\u00a0\u00a0\u00a0 <\/span>Conclusions:\u00a0While much of the data needs to be analyzed, there does appear to be significant benefits to the incorporation of IORT into a multimodal surgical treatment for patients with locally advanced and recurrent rectal cancer.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">SPINAL PATHWAYS ACTIVATED WITH THE STIMULATION OF THE HYPOGASTRIC NERVE IN FEMALE RATS<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">UGOEKE, J., YU, G-Z., AND MARSON, L<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Recent studies in women and female rats suggest that activation of the sympathetic nervous system can facilitate sexual genital responses. In addition, women with injury of the spinal cord below the sympathetic region can still experience sexual arousal. To further understand the spinal pathways and mechanisms involved in relaying afferent and efferent information during sexual behavior; the present study examined the location of neurons in the spinal cord and lower brainstem that were activated with stimulation of the hypogastric nerve.\u00a0&#8221; &#8220;Mapping of c-fos, an immediate early gene that is expressed when cells are activated, was used to localize the spinal segments and regions that were activated with stimulation of the hypogastric nerve. Animals were anesthetized and the left hypogastric nerve was exposed. Control rats received similar surgical manipulation, except that the nerve was not stimulated, 2 other groups received either 40uA or 100uA stimulation over a 30min period. Animals were subsequently perfused and the brain and spinal cord was cut and stained using immunocytochemistry to visualize the fos-immunoreactive nuclei using standard techniques. Comparisons were done with t-test to examine any difference between segmental activation between stimulated and control animals.\u00a0&#8221; &#8220;Hypogastric nerve stimulation with 40uA resulted in a significant increase in cell activation in T12-L1 of the spinal cord, particularly in the dorsal horn, medial and lateral gray. Some increase in cell activation was also observed in the ventral horn of L3-L4.\u00a0In the L5-S1, 40uA stimulation resulted in increased c-fos in the medial and lateral gray. The group stimulated with 100uA showed less cell activation compared to the 40uA stimulated group. C-fos expression was found in the nucleus of solitary tract and the dorsal motor nucleus of the vagus nerve, with more expression seen in stimulated animals, especially in the dorsal motor of the vagus. These results map the spinal segments and regions that relay afferent information from the hypogastric nerve and suggest that stimulation of the hypogastric nerve activates vagal afferents. This information will aid our understanding of sensations and ability for sexual arousal after spinal cord injury.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Effects of Supplemental Oxygen Treatment on Oxygen-Induced Retinopathy in Neonatal Rats<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">A.Uppal, Y.Saito, D.K. Sutton, P.Geisen, G.Cui, L.J. Peterson, M.E. Hartnett.<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><strong><u><span style=\"font-size: 10pt;\">Purpose<\/span><\/u><\/strong><strong><span style=\"font-size: 10pt;\">:<\/span><\/strong><span style=\"font-size: 10pt;\"> Retinopathy of prematurity is a leading cause of vision loss in children.\u00a0 This study investigates the effects of supplemental oxygen treatment on retinopathy in neonatal rats using oxygen stresses similar to those experienced by pre-term infants.\u00a0\u00a0 <strong><u>Methods<\/u>:<\/strong> We used a 50\/10 oxygen-induced retinopathy (OIR) model that exposes Sprague-Dawley newborn rat pups to cycles of 24 h of 50% oxygen alternating with 24 h of 10% oxygen until postnatal 14 days (p14). Some of the litters were then exposed to 28% O<sub>2<\/sub> (OIR+SO model) until p20 while others were moved to room air (OIR model). Pups were given IP injections of Pimonidazole (Hypoxyprobe: HP) 90 minutes before sacrifice and retinal dissection. Half of the retinas were fixed for flatmounts or cryosections and stained with<em> Griffonia simplicifolia <\/em>isolectin and HP antibody, while the rest were collected for western blot analysis of HP vs. actin levels. The flat mounts were scored for intravitreous neovascularization (IVNV) by counting clock hours and for avascular areas as a percent of total retinal area (%AVA) using Image J (NIH). Data was analyzed by Mann-Whitney U-test and ANOVA using SPSS software.\u00a0\u00a0 <strong><u>Results<\/u>: <\/strong>HP was significantly increased at p18 vs. p13 and p17 vs p13 in the OIR model (one-way ANOVA p=0.002 &#038; Bonferroni p<0.05), and was observed to localize within the ganglion cell layer to outer nuclear layer of peripheral avascular retina in flatmounts and cryosections. There was no significant difference between OIR+SO model and OIR model at p20 in clock hours IVNV (SO: 3.7\u00b11.0 S.E., OIR: 4.2\u00b10.6), %AVA (SO: 7.30%\u00b11.24, OIR: 9.26%\u00b11.63) or retinal HP levels.\u00a0\u00a0 <strong><u>Conclusion<\/u>: <\/strong>Supplemental oxygen might not be useful for reducing retinal hypoxia, neovascularization or peripheral avascularity following oxygen-induced retinopathy.\u00a0 Hypoxyprobe proved to be a useful tool for locating and quantitatively measuring hypoxic areas of the retina.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Inhibition of NAD(P)H Oxidase Activity Reduces Intravitreous Neovascularization after Oxygen Stress in a Rat Model of Retinopathy of Prematurity<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Y.Saito, A.Uppal, G. Byfield, S. Budd, M.E. Hartnett<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Purpose: Retinopathy of prematurity is a leading cause of vision loss in children.\u00a0This study measures NAD(P)H oxidase-dependent outcomes after oxygen stresses, similar to those experienced by preterm infants today, using a rat model of retinopathy of prematurity.\u00a0\u00a0\u00a0 Methods: Within 4 hours of birth, pups and their mothers were cycled between 50% and 10% oxygen daily for 14 days, and returned to room air (21% O2, 50\/10OIR) or supplemental oxygen (28% O2, 50\/10OIR SO) for four days. Pups received intraperitoneal injections of the specific NAD(P)H oxidase inhibitor, apocynin (10 mg\/kg\/day), or PBS from postnatal day (p)12-p17, and some received intraperitoneal injections of pimanidazole (Hypoxyprobe: HP) prior to sacrifice. Outcomes were intravitreous neovascularization (IVNV) and avascular\/total retinal areas, VEGF, phosphorylated\/total p47phox, and hypoxic retina (conjugated HP). Human retinal microvascular endothelial cells (RMVECs) treated with apocynin or PBS were exposed to 1% or 21% O2 and assayed for phosphorylated JNK and p47phox.\u00a0\u00a0\u00a0 Results: Compared to 50\/10OIR, 50\/10OIR SO had increased NAD(P)H oxidase activation (phospho- p47phox), reduced VEGF, but not less hypoxic retina. 50\/10OIR SO treated with apocynin had less hypoxic retina and IVNV area, but not reduced VEGF. RMVECs treated with 1% O2 had increased signaling through JNK than did cells exposed to room air.\u00a0\u00a0\u00a0 Conclusions: Varying degrees of NAD(P)H oxidase activation by different oxygen stresses differentially trigger signaling pathways leading to angiogenesis (IVNV) or apoptosis (avascular retina), features important in severe ROP. NAD(P)H oxidase dependent IVNV appears to involve pathways besides VEGF.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Risk Factors for Dengue in Laredo, Trujillo, Peru<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Anshu Verma<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Dengue is a mosquito-borne viral illness whose incidence has increased continuously in South America over the last 25 years.\u00a0Many people view this increase as a failure in the politics of public health in this region.\u00a0Peru, in particular, has noticed a reemergence of dengue in the past two decades.\u00a0The purpose of this project was to examine awareness of risk factors for dengue and risk behaviors in the community of Laredo, in Trujillo, La Libertad, Peru.\u00a0We surveyed households in the community about their practices concerning water storage, raising animals, use of mosquito nets while sleeping during the summer.\u00a0Overall, we found that the community was well aware of risk factors and was taking appropriate steps to avoid dengue outbreaks.\u00a089% of the households surveyed reported storage of water in their homes.\u00a0Of these households, 88% reported using something to cover the containers in which water was stored.\u00a052% reported emptying and cleaning their water storage containers each day, 44% reported doing so every 2-3 days, and 4% reported doing so once weekly.\u00a044% reported raising animals domestically in their homes.\u00a012% reported use of mosquito nets while sleeping during the summer.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 14pt;\">Diversity of IGRP-specific CD8\u00a0T cells in NOD mice<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Benjamin Vincent, Adam Buntzman, Ellen Young, Tom Kepler, Jeff Frelinger<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><strong><span style=\"font-size: 10pt;\">Background \/ Objectives\u00a0 <\/span><\/strong><span style=\"font-size: 10pt;\">The non-obese diabetic (NOD) mouse develops autoimmune-mediated beta-islet destruction and provides a model for the study of type I diabetes (T1D).\u00a0 It has been shown in our group that the diversity of a cell population important in diabetegenesis (IGRP<sub>206-214<\/sub>-specific CD8<sup>+<\/sup> T-cells) is exquisitely low in the pancreatic islets and peripheral blood of 20wk-old NOD mice.\u00a0 It is important to know whether this restriction obtains in younger mice, whether tissue-specific differences in diversity exist, and to what degree there is overlap in IGRP<sub>206-214<\/sub>-specific T cell pools between mice, tissues, and ages.\u00a0\u00a0\u00a0 <strong>Methods\u00a0 <\/strong>IGRP<sub>206-214<\/sub>-specific CD8<sup>+<\/sup> T cells were isolated from various tissues of NOD mice at ages 8-16 weeks then single-cell sorted.\u00a0 RT\/PCR was done on the single-cell lysates and product dna was sequenced.\u00a0 TCR-beta gene usage was determined using the SoDA software tool.\u00a0 Population diversity accounting for unseen species was calculated using a novel method developed by one author TK).\u00a0\u00a0<strong>Results\u00a0 <\/strong>The diversity of the IGRP<sub>206-214<\/sub>-specific CD8<sup>+<\/sup> T cell population was significantly lower in islets &#038; pancreatic lymph nodes (PLNs) and higher in the spleen and thymus at 8 weeks.\u00a0 Diversity in the spleen and thymus remained high for all time points.\u00a0 At 10 weeks, islet and PLN diversity had increased, but by twelve weeks had decreased to a midpoint between 8 week and 10 week levels.\u00a0 Through 12 weeks, diversities in the islets and PLNs were statistically indistinguishable.\u00a0 After 12 weeks, diversity in the islets dropped precipitously while diversity in the PLNs was relatively unchanged.\u00a0 The decrease in islet diversity was determined by both a declining overall species richness and an increasing frequency of the most abundant clonotypes.<span>\u00a0\u00a0 <\/span><strong>Conclusions\u00a0 <\/strong>After 10 weeks, IGRP<sub>206-214<\/sub>-specific CD8<sup>+ <\/sup>T cells concentrate in the islets and the pancreatic lymph nodes and this concentration increases disproportionately in the islets over time.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">An Improved Technique of Use of the Temporary Keratoprosthesis in Eye Trauma Surgery<\/span><\/p>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Watson J, Landers MB.<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Use of a temporary keratoprosthesis (TKP) in eye surgery to establish both a water-tight seal and a clear view of the posterior segment of the eye can be helpful in cases of ocular trauma where assessment of the retina and vitreous is prevented by corneal edema, inflammation, or intraocular bleeding.\u00a0Using a TKP during ocular trauma surgery may be perceived to be difficult because of the conventional wisdom that a water-tight seal must be maintained between the opposing corneal stroma and TKP trunk.\u00a0Traditionally this is accomplished by the use of a TKP with a trunk diameter that is very slightly greater than the trephined opening in the injured cornea.\u00a0However, we used the Landers TKP #2 to successfully establish a water-tight seal on the horizontal interface between the circumferential TKP flange and the anterior surface of the cornea rather than between the corneal stroma and TKP trunk, allowing us to use a TKP whose trunk was 0.8mm smaller than the diameter of the corneal opening.\u00a0Twenty postmortem porcine eyes had a PMMA TKP #2 with a 7.2mm wide-field trunk secured into an 8.0mm trephination hole with six 5-0 Vicryl sutures after removal of the lens and capsule.\u00a0Each eye was pressurized to 100mmHg and the seal between the TKP and corneal surface tested for leaking fluid.\u00a0All twenty eyes were found to be water-tight.\u00a0A standard pars plana vitrectomy was performed on sixteen of twenty eyes, and fifteen of these remained water-tight to 100mmHg.\u00a0The Landers TKP #2 can be used to maintain a clear view of the posterior segment and a water-tight eye in cases where the corneal defect is up to 0.8mm greater in diameter than the TKP trunk, and\/or where the original traumatic corneal injury precludes a tight seal between the corneal stroma and TKP trunk.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents By Four American Universities<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 10pt;\">Rebecca Wertman; Ersan Altun, MD; Richard Semelka, MD; et. al<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Purpose: To determine the benchmark incidence of NSF in tertiary care centers of four different universities in the United States (University of North Carolina at Chapel Hill, Emory University, Thomas Jefferson University, and Wake Forest University) related to confirmed usage of different gadolinium chelate contrast agents.\u00a0\u00a0\u00a0 Materials and Methods: Institutional review board approvals with waiver of informed consents were obtained for this HIPAA compliant retrospective multi-institutional study. Patient records from the databases of Dermatology, Pathology, Internal Medicine, Nephrology, Transplant Surgery and Radiology were cross-referenced to identify all patients with NSF at the four tertiary care centers ranging from January 2000 to December 2006. All centers had renal transplant and dialysis services. The type of agent, number of studies, and volume of gadolinium chelate contrast agent (GCCA) administered to the patients with NSF were determined in each center using a created checklist. The checklist included the search of technologists\u2019 log book, clinical information system, MRI study headers, MR images and reports to confirm the GCCA used. Laboratory data including serum creatinine and estimated glomerular filtration rate (eGFR) were determined. Additionally, the benchmark incidence of NSF was determined for the same time period as the number of patients with NSF relative to the number of patients having undergone GCCA enhanced MRI in each tertiary care center.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Results: Two centers utilized gadopentate dimeglumine and two centers utilized gadodiamide as the solitary gadolinium agent during the study period. The incidence of NSF was 1 in 44,225 patients with gadopentate dimeglumine and 1 in 2,913 patients with gadodiamide.\u00a0\u00a0\u00a0 Conclusion: The checklist verified the different GCCAs administered to the patients with NSF. We observed a benchmark incidence of NSF of 1 in 44,225 for gadopentate dimeglumine and of 1 in 2,913 for gadodiamide.\u00a0<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Predictive Value of EBV Loads for Post-Transplantation Lymphoproliferative Disease in Lung Transplant Recipients<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">S. Wheless, M. Gulley, P. McNellie, I. Neuringer, and R.M. Aris<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">BACKGROUND: Post-transplantation lymphoproliferative disorder (PTLD) is a well-documented and often fatal complication of transplantation.\u00a0Lung transplant recipients are at the greatest risk for PTLD.\u00a0We aim to determine if elevated EBV loads, in combination with other predictive factors, may serve as a reliable diagnostic marker of PTLD risk in lung transplant recipients.\u00a0METHODS: A retrospective, single-center study was performed using real-time TaqMan PCR EBV DNA load data in lung transplant recipients.\u00a0The study population included all patients transplanted from 1990 to the present.\u00a0Results were correlated with pre-transplant EBV status and development of PTLD.\u00a0RESULTS: EBV load testing from 2000 forward has yielded approximately 1000 viral loads in 119 lung transplant recipients.\u00a0Of these, 13 developed PTLD (12 confirmed histologically).\u00a0Among pre-transplantation seropositive patients, 1 developed PTLD; the EBV load was >250copies\/mL (true positive) (sensitivity and specificity 100%).\u00a0Among the pre-transplantation seronegative patients, 12 developed PTLD.\u00a0Of these, only 4 had EBV load data and all had detectable EBV DNA (sensitivity 100%, specificity 21.4%), but only 2 of 4 had EBV loads >250copies\/mL (sensitivity 50%, specificity 57.1%).\u00a0The lower rates of specificity were mostly due to false signal in non-PTLD cases and were load-level dependent [i.e. depending on whether one considered the positive as >250 (the assay positive) or as >0 (any detectable EBV)].\u00a0Thus, pre-transplant EBV status affects the performance of the assay.\u00a0CONCLUSION: EBV loads are a useful but imperfect indicator of PTLD risk in lung transplant patients.\u00a0Our EBV data are similar to published CMV PCR data; both tests have excellent negative predictive value.\u00a0The main shortcoming of EBV viral load testing is that many EBV seronegatives who fail to develop PTLD have false positive results \u2013 likely due to primary EBV infection.\u00a0EBV load testing requires further investigation and refinement before it can be used to accurately determine PTLD risk.<\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p align=\"center\"><span style=\"font-size: 14pt;\">Effectiveness of the Protocol for the Assessment of Neurodevelopmental Function in Early Infancy (PANDI)<\/span><\/p>\n<div align=\"center\">\u00a0<\/div>\n<div align=\"center\"><span style=\"font-size: 10pt;\">Stephanie Wolfe<\/span><\/div>\n<div align=\"center\">\u00a0<\/div>\n<div style=\"border-style: none none solid; border-color: -moz-use-text-color -moz-use-text-color windowtext; border-width: medium medium 1.5pt; padding: 0in 0in 1pt;\">\n<p style=\"border: medium none ; padding: 0in;\"><span style=\"font-size: 10pt;\">Background: Although a significant portion of children have developmental delays, many are not diagnosed until school age, and when they are, it is difficult to translate this diagnosis into qualification for services.\u00a0In addition, newborn screenings for genetic and metabolic disease are increasingly available, and early intervention services become more available, yet current assessments to determine the implications and recommended treatment for these diagnoses are lacking. Lastly, parents are not getting the information they need to help their children with these problems.\u00a0The Protocol for the Assessment of Neurodevelopmental Function in Early Infancy (PANDI) was created to address these issues.\u00a0\u00a0\u00a0\u00a0\u00a0 Aims: This study is to verify that the Protocol for the Assessment of Neurodevelopmental Function in Early Infancy (PANDI) can detect infants with developmental weaknesses, predict future developmental delay, and provide understanding of the infant\u2019s status to clinicians, parents, and community providers.\u00a0\u00a0\u00a0 Methods: Premature and full term babies will be assessed at 38-48 weeks gestational age using the PANDI.\u00a0The Mullen Scale of Early Learning and the Cognitive Adaptive Test\/Clinical Linguistic and Auditory Milestone Scale (CAT\/CLAMS) will also be scored from this exam.\u00a0Children will be\u00a0reassessed using the Mullen and CAT\/CLAMS at 12-18 months.\u00a0Babies that have previously received the PANDI as part of their clinical care will also be contacted for follow-up using the Mullen and CAT\/CLAMS.\u00a0Surveys will be given to clinicians, parents, and community providers to determine if they thought use of the PANDI was helpful.\u00a0Surveys and results from the PANDI will be compared to these other tests to determine aims.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Results:\u00a0Preliminary data suggests that the PANDI can diagnose newborns with neurodevelopmental delays better and quicker than other assessments and that clinicians, parents, and community providers feel that the PANDI meets their needs more than current standards of care.\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/p>\n<\/div>\n<div>\u00a0<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A Novel Methodology for Endothelial Progenitor Cell Enumeration in Clinical Trials Based on Mononuclear Cell Cryopreservation \u00a0 Stacie Adams BS, Sunil V. Rao MD, Robert A. Harrington MD, Thomas J. Povsic MD PhD \u00a0 Background:\u00a0 Increasing evidence of the role played by circulating endothelial progenitor cells (EPCs) in vascular repair has led to interest in &hellip; <a href=\"https:\/\/www.med.unc.edu\/dms\/past-issues\/2007-2008-edition\/40th-annual-john-b-graham-research-society-abstracts\/\" aria-label=\"Read more about 40th Annual John B. Graham Research Society Abstracts\">Read more<\/a><\/p>\n","protected":false},"author":80868,"featured_media":0,"parent":2239,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-2299","page","type-page","status-publish","hentry","odd"],"acf":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/pages\/2299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/users\/80868"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/comments?post=2299"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/pages\/2299\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/pages\/2239"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/dms\/wp-json\/wp\/v2\/media?parent=2299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}